Medical device system and method for sensing respiration phases
The medical device system uses a respiration vector from a motion sensor to accurately identify inspiration and expiration phases, enhancing respiration monitoring and therapy delivery by detecting phase-dependent signal features.
Patent Information
- Application Number
- PCT/IB2026/054123
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-05
- Filing Date
- 2026-04-27
- Publication Date
- 2026-11-12
AI Technical Summary
Existing medical devices struggle to accurately identify and discriminate between inspiration and expiration phases of respiration cycles due to variable orientation of motion sensors relative to respiratory motion, which affects the reliability of respiration monitoring and therapy delivery.
A medical device system that determines a respiration vector from a motion sensor signal to identify the direction of motion during inspiration and expiration phases, using a motion sensor such as an accelerometer to detect phase-dependent signal features for precise monitoring and therapy control.
Enables reliable monitoring of respiration metrics and effective therapy delivery by positively identifying and discriminating between inspiration and expiration phases, improving patient care through phase-dependent monitoring and therapy delivery.
Smart Images

Figure IB2026054123_12112026_PF_FP_ABST
Abstract
Description
Atty Ref. No. A0013476W001MEDICAL DEVICE SYSTEM AND METHOD FOR SENSING RESPIRATION PHASES
[0001] This application claims the benefit of U.S. Provisional Patent Application Serial No. 63 / 799,905, filed May 5, 2025, the entire content of which is incorporated herein by reference.TECHNICAL FIELD
[0002] This disclosure relates to a medical device system and method for sensing respiration phases for performing and controlling a respiration-phase dependent function.BACKGROUND
[0003] A variety of medical devices for delivering a therapy and / or monitoring a physiological condition have been used clinically or proposed for clinical use in patients. Examples include medical devices that deliver therapy to and / or monitor conditions associated with the heart, muscles, nerves, brain, stomach or other organs or tissue or a patient. Some medical devices may employ one or more electrodes for the delivery of therapeutic electrical signals to such organs or tissues and / or one or more electrodes for sensing intrinsic electrical signals within the patient that are generated by such organs or tissue. Similarly, some medical devices may additionally or alternatively include one or more other sensors for sensing physiological signals of a patient and monitoring a physiological condition.
[0004] For example, some medical devices may function as cardiac pacemakers or cardioverter-defibrillators that provide therapeutic electrical signals to the patient’s heart. In some examples, a medical device may sense intrinsic depolarizations of the heart and thereby control delivery of therapeutic signals to the heart based on the sensed depolarizations. Upon detection of an abnormal rhythm, such as bradycardia, tachycardia, or fibrillation, an appropriate therapeutic electrical signal or signals may be delivered to restore or maintain a more normal heart rhythm. For example, in some cases, an implanted medical device may deliver pacing stimulation to the heart of the patient upon detecting tachycardia or bradycardia, and / or deliver cardioversion or defibrillation shocks to the heart upon detecting fibrillation.Atty Ref. No. A0013476W001
[0005] Some medical devices that are implanted within a patient’s body may include a motion sensor for sensing patient body motion such as patient physical activity, cardiac motion and / or respiratory motion. Respiratory motion, for example, may be used for monitoring physiological conditions associated with respiratory function of the patient and / or for use in controlling a therapy delivered by a medical device, such as cardiac pacing rates delivered by a cardiac pacemaker or implantable cardioverter defibrillator (ICD).SUMMARY
[0006] The techniques of this disclosure provide a medical device system and method for sensing respiration phases from a motion sensor signal with distinct sensing of the inspiration and respiration phases for use in performing respiration-phase dependent functions, such as inspiration monitoring, expiration monitoring and / or therapy delivery control. The medical device system may determine a respiration axis of displacement from a motion sensor signal for determining a direction of motion or displacement during respective inspiration and expiration phases of a patient’s respiration cycle. Respiration motion may occur along a primary respiration vector in a first direction during the inspiration phase and during a second, opposite direction along the primary respiration vector during the expiration phase.
[0007] In a medical device system operating according to the techniques disclosed herein, processing circuitry of the medical device system may receive the motion sensor signal, determine a respiration vector, identify the direction of displacement during inspiration and expiration phases along the respiration vector, and based on the identified inspiration and expiration phases, identify one or more signal features for discriminating between the inspiration and expiration phases of the respiratory cycle. The signal feature(s) may include one or more features of a signal sensed by the IMD. The inspiration and / or expiration phases of respiration may be sensed by the IMD by detecting the phase dependent signal feature(s). Sensing of inspiration and / or expiration phases may be used by the IMD in determining a phase-dependent respiration metric and / or controlling a phase-dependent therapy delivered by the IMD in various examples.
[0008] In one example, the disclosure provides a medical device system including sensing circuitry configured to sense one or more signals, the sensing circuitry including at least a motion sensor sensing a motion signal. The medical device system further includes controlAtty Ref. No. A0013476W001circuitry configured to receive the motion signal sensed by the motion sensor for at least one respiration cycle and determine from the motion signal a respiration vector representative of directions of motion during the at least one respiration cycle. The control circuitry may be configured to identify a first direction of motion along the first respiration vector corresponding to a first respiration phase that is one of an inspiration phase or an expiration phase of the at least one respiration cycle and, from the one or more signals sensed by the sensing circuitry, identify a first phase-dependent signal feature that occurs in timed relation with the first direction of motion along the first respiration vector. The control circuitry may sense respiration phases by detecting the first phase-dependent signal feature. The control circuitry may perform a phase-dependent monitoring and / or therapy delivery function in response to sensing the respiration phases.
[0009] In another example, the disclosure provides a method including sensing one or more signals including at least a motion signal sensed by a motion sensor, sensing the motion signal for at least one respiration cycle and determining, from the motion signal, a respiration vector representative of directions of motion during the at least one respiration cycle. The method may include identifying a direction of motion along the respiration vector corresponding to a first respiration phase that is one of an inspiration phase or an expiration phase of the at least one respiration cycle and, from the one or more sensed signals, identifying a phase-dependent signal feature that occurs in timed relation with the direction of motion along the respiration vector. The method may further include sensing respiration phases by detecting the first phase-dependent signal feature. The method may further include performing a phase-dependent monitoring and / or therapy delivery function in response to sensing the respiration phases.
[0010] In another example, the disclosure provides a non-transitory computer readable medium storing instructions which, when executed by control circuitry of a medical device system, cause the medical device system to sense one or more signals including at least a motion signal sensed by a motion sensor, sense the motion signal for at least one respiration cycle and determine from the motion signal a respiration vector representing directions of motion during the at least one respiration cycle. The instructions may further cause the medical device system to identify a direction of motion along the respiration vector corresponding to one of an inspiration phase or an expiration phase of the at least one respiration cycle and, from the one or more sensed signals, determine a phase-Atty Ref. No. A0013476W001dependent signal feature that occurs in timed relation with the identified direction of motion along the respiration vector. The instructions may further cause the medical device system to sense respiration phases by detecting the phase-dependent signal feature. The medical device system may perform a phase-dependent monitoring and / or therapy delivery function in response to sensing the respiration phases.
[0011] The details of one or more aspects of the disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the techniques described in this disclosure will be apparent from the description and drawings, and from the claims.BRIEF DESCRIPTION OF DRAWINGS
[0012] FIG. l is a diagram illustrating an IMD system that may be configured to perform the techniques for sensing respiration phases disclosed herein.
[0013] FIG. 2 is a conceptual diagram of the IMD shown in FIG. 1.
[0014] FIG. 3 is a diagram of an example configuration of an IMD of a medical device system configured to positively and distinctly detect the inspiration and expiration phases of respiration cycles according to the techniques disclosed herein.
[0015] FIG. 4 is a flow chart of a method that may be performed by a medical device system for sensing respiration phases according to some examples.
[0016] FIG. 5 is a flow chart of a method that may be performed by a medical device system for sensing respiration phases according to another example.
[0017] FIG. 6 is a flow chart of a method for sensing respiration phases with positive identification of inspiration and expiration by a medical device according to some examples.
[0018] FIG. 7 is a diagram of accelerometer axis signals that may be received by the IMD of FIG. 3 over a respiration cycle.
[0019] FIG. 8 is a diagram of a respiration vector that may be determined by a medical device system according to the techniques disclosed herein.
[0020] FIG. 9 is a diagram depicting an orienting signal input that may be sensed or received by the medical device system for positively identifying a direction of motion along a respiration vector corresponding to a respiration phase according to one example.Atty Ref. No. A0013476W001
[0021] FIG. 10 is a diagram of an orienting signal input that may be sensed or received by the medical device system according to another example.
[0022] FIG. 11 is a diagram of a signal that may be sensed by the IMD of FIG. 4 and analyzed over one or more respiration cycles of positively identified respiration phases for identifying a phase-dependent signal feature that occurs in timed relation to the determined directions of motion along the respiration vector during each respiration phase and can subsequently be used for sensing respiration phases.DETAILED DESCRIPTION
[0023] In general, this disclosure relates to a medical device system and techniques for sensing respiration phases with positive identification and discrimination of the inspiration and / or expiration phases. In some examples, the respiration phases may be sensed from a signal sensed by a medical device by detecting a respiration phase-dependent change in a feature of the sensed signal. The phase-dependent change in the signal feature corresponding to a positively identified respiration phase, e.g., inspiration or respiration, can be identified by the medical device by determining a respiration vector from a motion sensor signal. The respiration vector is representative of the primary directions of motion during the inspiration phase (in a first direction) and during expiration (in a second opposite direction) along the respiration vector, for example. The medical device may identify the direction of motion along the respiration vector due to respiration during a given respiration phase, e.g., inspiration or expiration. A phase-dependent change in a feature of a signal sensed by the medical device, that occurs during the given respiration phase, can be identified when motion is occurring in the corresponding direction along the respiration vector. The phase-dependent change in the signal feature can be subsequently detected by a medical device for sensing respiration phases by the medical device. The term “phase-dependent” is used herein with regard to dependency on or affected by the respiration phase, e.g., inspiration or expiration. As such, a phase-dependent signal feature can be a feature of a signal sensed by the medical device that is identified to occur during or in conjunction with a given direction of motion along the respiration vector for a corresponding respiration phase. The phase-dependent signal feature can be identified as having a characteristic value of the signal feature (e.g., meeting a threshold or range) and / or trend of the signal feature (e.g., increasing, decreasing or unchanging).Atty Ref. No. A0013476W001
[0024] The medical device may be an implantable medical device (IMD) including a motion sensor. The motion sensor may be an accelerometer, gyroscope, magnetometer or other motion sensor or any combination thereof that is capable of sensing a motion signal that is responsive to respiratory motion of a patient. The motion sensor may be subjected to forces due to respiration resulting in changes in acceleration in directions relative to the patient’s body that may be unpredictable. The direction of displacement due to respiratory motion during the inspiration and expiration phases, for example, may be unknown when the orientation of the IMD relative to the patient’s body is unknown and can be variable depending on patient posture, cardiac motion, patient physical activity and other acceleration forces exerted on the IMD and motion sensor. The IMD and motion sensor position relative to respiratory motion of the patient’s chest or abdomen at the time of implant may be uncontrolled to at least some extent and may vary between patients and overtime. Certain pathological conditions may alter typical characteristics of inspiration and expiration phases of a respiration signal. For example, the inspiration phase is typically shorter than the respiration phase in a healthy person and the rate of change of a respiration signal during the inspiration phase is typically faster than during the expiration phase in a healthy person. However, in some patients suffering from an illness or disease, a respiration signal sensed by a medical device may not conform to the patterns or characteristics expected to be observed in the respiration signal in a healthy patient. As such, various factors can contribute to the inability to positively identify the inspiration and expiration phases of a signal sensed by an IMD when the orientation of the motion sensor relative to the respiration motion is not known or is variable.
[0025] Accordingly, the techniques set forth herein provide specific improvements in the field of medical devices that have practical applications. By providing a medical device system configured to determine a respiration vector from a motion sensor signal and identify the direction of motion along the respiration vector during each of the inspiration and expiration phases, the performance of the medical device in monitoring respiratory function, monitor pathological conditions associated with respiration, and / or control therapies delivered by a medical device system in coordination with the respiration phases can be improved. The techniques disclosed herein provide improvements in monitoring of a respiration signal and particularly in sensing respiration phases with positive identification and discrimination of inspiration and expiration phases. Such improvementsAtty Ref. No. A0013476W001enable a medical device system to reliably monitor respiration metrics that may be phase dependent, e.g., determining metrics of respiration corresponding to inspiration function (e.g., peak acceleration during inspiration, inspiration phase duration, maximum slope of acceleration during inspiration, etc.) and / or determining metrics of respiration that correspond to expiration function (e.g., peak acceleration during expiration, expiration phase duration, maximum slope of acceleration during expiration, etc.). Such metrics can be used by the IMD and / or transmitted to an external device for review by a user in monitoring for pathological changes or worsening respiratory conditions relating to respiration effort during inspiration and / or expiration or the like. Additionally or alternatively, when the IMD or another medical device of the medical device system is configured to deliver a respiration phase-dependent therapy, positively detecting and discriminating the respiration phases with high confidence can promote appropriate and effective therapy delivery. Examples of respiration phase-dependent therapies that may be delivered by a medical device system are described below.
[0026] FIG. 1 is a diagram illustrating an IMD system 10 that may be configured to perform the techniques for sensing respiration phases disclosed herein. The illustrative examples provided herein generally relate to cardiac devices, e.g., cardiac monitors or cardiac pacemakers, used to sense cardiac signals and / or deliver electrical stimulation therapy to a patient’s heart. Such devices may be further configured to monitor the patient’s respiration for determining respiration metrics and / or controlling a respiration phase-dependent therapy delivered by the IMD system. It is to be understood, however, that the techniques disclosed herein may be implemented in a wide variety of IMD systems that include an IMD having a motion sensor, e.g., an accelerometer that is responsive to the patient’s respiratory movement. Among the IMDs that may be included in a medical device system configured to perform the techniques disclosed herein are, with no limitation intended, cardiac monitors, cardiac pacemakers, cardioverter-defibrillators, neurostimulators (e.g., brain stimulators, spinal cord stimulators, sensory or autonomic nerve stimulators, etc.), muscular or neuromuscular stimulators (e.g., gastric stimulators, diaphragm stimulators, skeletal muscle stimulators or somatic nerve stimulators, etc.), drug pumps, cardiac assist devices such as artificial heart or left ventricular assist devices, and other sensors or monitors such as glucose monitors, tissue or blood oxygen monitors, etc.Atty Ref. No. A0013476W001
[0027] IMD system 10 includes an IMD 14 configured to communicate with an external device 50 via a wireless communication link 55. In the example shown, IMD 14 is a leadless, transcatheter intracardiac pacemaker adapted for implantation wholly within a heart chamber, e.g., wholly within a ventricle (such as in the right ventricle (RV) as shown) or wholly within an atrium (e.g., the right atrium (RA)) of heart 8 for sensing cardiac signals and delivering cardiac pacing pulses. IMD 14 may be reduced in size compared to subcutaneously implanted pacemakers and may be generally cylindrical in shape to enable transvenous implantation via a delivery catheter. IMD 14 is shown positioned in the RV, along an endocardial wall, e.g., near the RV apex though other locations are possible. For example, IMD 14 may be positioned in or on (e.g., epicardially) the RV, LV, RA or left atrium of heart 8 and may be implanted along the inter-ventricular septum in some examples. In the example shown, IMD 14 is positioned within the RV to sense cardiac and respiration signals and provide ventricular pacing. In other examples, IMD 14 could be positioned to provide ventricular pacing and sensing (and respiration phase sensing) from a right atrial approach. For instance, IMD 14 may be positioned in the RA, and a tissue-piercing distal electrode of IMD 14 may be advanced into the interatrial septum toward the His bundle, e.g., at the inferior end of the interatrial septum. A distal electrode extending from IMD 14 may be advanced toward the His bundle from a location beneath the AV node and near the tricuspid valve annulus, generally in the Triangle of Koch, to position the distal electrode near the His bundle from a right atrial approach for providing ventricular pacing and sensing from an IMD implant position in the RA.
[0028] IMD 14 may be capable of producing electrical stimulation pulses, e.g., pacing pulses, delivered to heart 8 via one or more electrodes on the outer housing of the pacemaker. IMD 14 is configured to deliver pacing pulses and sense a cardiac electrical signal using housing based electrodes for producing a cardiac electrogram (EGM) signal. The cardiac electrical signals may be sensed using the housing based electrodes that are also used to deliver pacing pulses, e.g., to the RV in the implant position shown.
[0029] IMD 14 may be configured to control the delivery of ventricular pacing pulses according to one or more pacing modes, e.g., an atrial asynchronous ventricular pacing mode or in an atrial synchronous ventricular pacing mode. For example, IMD 14 may include a motion sensor that is responsive to cardiac motion for sensing cardiac mechanical event signals. IMD 14 may sense atrial motion from the motion sensor signalAtty Ref. No. A0013476W001for enabling IMD 14 to deliver ventricular pacing pulses synchronous to atrial contractions to promote normal synchrony between atrial activation and ventricular activation. The motion sensor of IMD 14 used for monitoring respiratory motion as described herein can be used by IMD 14 for detecting cardiac mechanical event signals for controlling atrial synchronous ventricular pacing. IMD 14 may deliver ventricular pacing pulses at a desired atrioventricular (AV) pacing interval after atrial contractions that are sensed from the motion sensor signal, for example. The motion sensor used for sensing respiration according to techniques disclosed herein may be used for sensing patient physical activity for controlling rate responsive pacing to provide ventricular rate support when the patient is physically active. A patient physical activity metric may be determined from the motion sensor signal so that the pacing rate can increase with patient physical activity and decrease again when the patient is at rest.
[0030] In some examples, IMD 14 may be configured to deliver respiratory sinus arrhythmia (RSA) pacing. RSA is the normal heart rate variability that can occur with respiration phases in young or healthy individuals. Cardiac pacing can be delivered at varying rates to restore heart rate variability that occurs with respiration phases.Modulation of the cardiac pacing rate between respiration cycles can be beneficial in patients suffering from heart failure or patients that have lost RSA. In a healthy normal heart, the intrinsic heart rate tends to rise through the inspiration phase and fall during the expiration phase. The intrinsic heart rate in a healthy individual can vary by 5 to 15 beats per minute and sometimes change by more than 30 beats per minute between inspiration and expiration phases. RSA can be an indication of balanced vagal tone because the parasympathetic influence may increase and decrease with each breath whenthe autonomic nervous system is properly balanced.
[0031] As such, a motion sensor included in IMD 14 can be used to sense respiration phases to enable IMD 14 to deliver RSA pacing. However, the phases of respiration need to be positively identified, with inspiration and expiration being discriminated from each other, in order to correctly increase the cardiac pacing rate during inspiration and decrease the cardiac pacing rate during expiration. The orientation of a motion sensor included in IMD 14 relative to respiratory motion may vary between patients, implant location, and due to cardiac and other patient body motion. The techniques disclosed herein provide methods for positively identifying the inspiration phase and the expiration phaseAtty Ref. No. A0013476W001independent of the orientation of the motion sensor with respect to cyclical cardiac motion, the patient’s anatomy or gravity. By positively identifying and detecting the inspiration and expiration phases, IMD 14 can modulate the pacing rate over the course of a respiration cycle to mimic RSAby providing respiration phase-dependent pacing rates.
[0032] The motion sensor included in IMD 14 may be an accelerometer that can be used for sensing respiration motion and in some examples may sense the orientation of IMD 14 relative to gravity, e.g., for detecting changes in patient posture, and in some examples, cardiac motion and / or patient physical activity motion as described above. As further described below, the accelerometer may be a single axis (one dimensional) or multi-axis (e.g., two dimensional, three dimensional, or other multi-dimensional) accelerometer.
[0033] IMD 14 may be capable of bidirectional wireless communication with an external device 50 for programming operating parameters and algorithms into IMD 14, e.g., pacing control parameters, cardiac signal sensing parameters, respiration sensing parameters, etc. External device 50 may be a dedicated IMD programmer used by a physician, technician, nurse, clinician or other qualified user for programming operating parameters in IMD 14. External device 50 may be located in a clinic, hospital or other medical facility. External device 50 may alternatively be embodied as a home monitor or a handheld device that may be used in a medical facility, in the patient’s home, or another location. In some examples, external device 50 may be a personal device such as a mobile phone, tablet, personal computer or other device capable of wireless communication with IMD 14.
[0034] External device 50 includes a telemetry unit 58, which may be configured for bidirectional communication with communication circuitry included in IMD 14. IMD 14 may include a communication circuit configured for radiofrequency distance telemetry and / or short range induction communication, as examples. External device telemetry unit 58 may include a transceiver and antenna configured for bidirectional communication with the communication circuit included in IMD 14.
[0035] Telemetry unit 58 is configured to operate in conjunction with processor 52 for sending and receiving data relating to IMD functions via communication link 55.Telemetry unit 58 may establish a wireless communication link 55 with IMD 14.Communication link 55 may be established using a radio frequency (RF) link such as BLUETOOTH®, BLUETOOTH® Low Energy (BLE), Wi-Fi, Medical Implant Communication Service (MICS) or other communication protocol. In some examples,Atty Ref. No. A0013476W001external device 50 may include a programming head that is placed proximate IMD 14 to establish and maintain a communication link 55 with IMD 14 via an antenna of IMD 14, and in other examples external device 50 and IMD 14 may be configured to communicate using a distance telemetry algorithm and circuitry that does not require the use of a programming head.
[0036] External device 50 may further include a processor 52, memory 53 and user interface 56 including a display unit 54. Processor 52 is coupled to the other components and units of external device 50, e.g., via a data bus, for controlling the functions attributed to external device 50 herein. Processor 52 may execute instructions stored in memory 53. Processor 52 may include any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), or equivalent discrete or analog logic circuitry. In some examples, processor 52 may include multiple components, such as any combination of one or more microprocessors, one or more controllers, one or more DSPs, one or more ASICs, or one or more FPGAs, as well as other discrete or integrated logic circuitry. The functions attributed to processor 52 herein may be embodied as software, firmware, hardware or any combination thereof.
[0037] Memory 53 may include any volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, or any other digital or analog media. Memory 53 may include non-transitory computer-readable media that store instructions that, when executed by processor 52, cause medical device system 10 to perform various methods and functions attributed to medical device system 10 as disclosed herein, alone or in combination with processing circuitry of IMD 14.
[0038] User interface unit 56 may include a mouse, touch screen, keypad or the like to enable a user to interact with external device 50, e.g., to initiate and terminate an interrogation session for retrieving data from IMD 14, adjust settings of display unit 54, enter programming commands or selections or make other user requests. Display unit 54, which may include a liquid crystal display, light emitting diodes (LEDs) and / or other visual display components, may generate a display of cardiac electrical signals received from IMD 14 and / or data derived therefrom. Display unit 54 may be configured toAtty Ref. No. A0013476W001generate a graphical user interface (GUI) including various windows, icons, user selectable menus, etc. to facilitate interaction by a user with the external device 50 and IMD 14. In some examples, display unit 54 may display a motion sensor signal to enable a clinician or other user to enter user input signals to truth respiration phases identified as inspiration or expiration by IMD 14.
[0039] Display unit 54 may function as an input and / or output device using technologies including liquid crystal displays (LCD), quantum dot display, dot matrix displays, light emitting diode (LED) displays, organic light-emitting diode (OLED) displays, cathode ray tube displays, e-ink, or monochrome, color, or any other type of display capable of generating tactile, audio, and / or visual output. In some examples, display unit 54 is a presence-sensitive display. Display unit 54 may serve as a user interface device that operates both as one or more input devices and one or more output devices.
[0040] It is contemplated that external device 50 may be in wired or wireless connection to a communications network via telemetry unit 58 that includes a transceiver and antenna or via a hardwired communication line for transferring data to a centralized database or computer to allow remote management of the patient. Remote patient management systems including a centralized patient database may be configured to enable a clinician to review cardiac signals, respiration signals and / or other sensor signals sensed by IMD 14, therapy delivery data and other device related data and authorize remote programming of IMD 14.
[0041] As disclosed herein IMD 14 may receive an orienting input signal transmitted by external device 50 in some examples. The orienting input signal may be transmitted to IMD 14 to provide IMD 14 with a timing signal or marker relative to a known inspiration phase so that IMD 14 can positively identify a direction of motion during one or both of the inspiration and expiration phases of the respiration cycle. The orienting input signal may be a timing marker that is transmitted by telemetry unit 58 in response to a clinician, patient or other user manually inputting a timing signal via user interface 56 to indicate the time of inspiration or the time of expiration.
[0042] In some examples, external device 50 may receive a respiration orienting signal from signal source 60. External device processor 53 may detect inspiration and / or expiration phases from the respiration orienting signal received from source 60. The respiration orienting signal is a signal that the timing of respiration phases can be reliablyAtty Ref. No. A0013476W001detected by external device processor 53. External device processor 50 may generate a timing signal in response to detecting an inspiration and / or an expiration phase from the respiration orienting signal. The timing signal can be transmitted by telemetry unit 58 to IMD 14 as the orienting input signal that is received by IMD 14 for use in determining the direction of respiration motion during a given respiration phase as further described below. The respiration orienting signal received from source 60 may be any of a variety of signals that are responsive to respiration cycle phases and may include, without limitation, an electrocardiogram (ECG) signal, a chest impedance signal, an acoustical signal, a blood oxygen saturation signal, a ventilation signal indicating the inspiration or expiration phase of a ventilator operating to provide respiratory support to the patient, etc.
[0043] In various examples, IMD system 10 may include two or more co-implanted IMDs. For the sake of illustration, a cardiac monitor 62 is shown co-implanted with IMD 14. Cardiac monitor 62 may have a pair of housing-based sensing electrodes 64. Cardiac monitor 62 may be implanted subcutaneously or submuscularly, for example, for sensing an ECG signal that may be recorded and stored by cardiac monitor 62 for transmission to external device 50. Cardiac monitor 62 may detect respiration phase-dependent changes in R-wave peak amplitude in the ECG signal for detecting the timing of inspiration and / or expiration phases of the respiration cycle in some examples.
[0044] Cardiac monitor 62 may be configured to communicate with IMD 14 as indicated by communication arrow 66, e.g., via radio frequency communication via a transceiver and antenna or via tissue conduction communication (TCC). Cardiac monitor 62 may transmit a timing signal or marker to IMD 14 as an orienting input signal that IMD 14 can receive for use in determining the direction of motion along a respiration vector during each respiration phase as further described below. In other examples, cardiac monitor 62 may sense impedance, blood oxygen saturation, lung and / or heart sounds, or other signals from which the timing of respiration phases can be detected to enable cardiac monitor 62 to generate and transmit a timing signal as an orienting input signal received by IMD 14 for determining the direction of respiration motion during respiration phases.
[0045] In some examples, IMD 14 may be co-implanted with another cardiac pacemaker or implantable cardioverter defibrillator. In the illustrative example shown, IMD 14 may be co-implanted with a second leadless pacemaker 12 that is implanted in the right atrium. Together, pacemaker 12 and IMD 14 may cooperatively provide dual chamber cardiacAtty Ref. No. A0013476W001sensing and pacing. As such, pacemaker 12 and IMD 14 may be configured to communicate as indicated by communication arrow 13, e.g., via radio frequency communication via a transceiver and antenna or via tissue conduction communication (TCC). In some examples, IMD 14 and pacemaker 12 may be configured to cooperatively deliver a phase-dependent therapy such as RSA pacing. For instance, IMD 14 may include a motion sensor that is used for positively identifying and sensing respiration phases according to the techniques disclosed herein. IMD 14 may transmit a respiration phase timing signal to pacemaker 12 to enable pacemaker 12 to modulate the atrial pacing rate to mimic RSA in synchrony with the detected respiration phases. In other examples, IMD 14 may be configured to transmit respiration phase timing signals to a co-implanted device that is configured to perform a phase-dependent function, such as determining a respiration phase-dependent monitoring metric and / or deliver a phase-dependent therapy.
[0046] FIG. 2 is a conceptual diagram of IMD 14 shown in FIG. 1. IMD 14 includes a housing 15 that encloses IMD circuitry, e.g., sensing circuitry, pulse generating circuitry, control circuitry, communication circuitry, and a power source as further described below in conjunction with FIG. 3. Housing 15 includes a longitudinal sidewall 17 extending between a distal end 26 and a proximal end 28, which may collectively define a hermetically sealed interior volume of IMD 14. Housing 15 may carry one or more electrodes 16 and 18 spaced apart along the housing 15 for sensing cardiac electrical signals and delivering electrical stimulation pulses. Electrode 16 is shown as a tip electrode extending from distal end 26. Electrode 18 is shown as a ring electrode along a mid-portion of longitudinal sidewall 17, for example adjacent proximal end 28. Electrode 18 may be referred to as a ring electrode because it may wholly circumscribe longitudinal sidewall 17. Distal end 26 is referred to as “distal” in that it is expected to be the leading end as IMD 14 is advanced through a delivery tool, such as a catheter, and placed against a targeted implant site.
[0047] Electrodes 16 and 18 form a cathode and anode pair for bipolar cardiac pacing and sensing. In other examples, IMD 14 may include two or more ring electrodes, two tip electrodes, and / or other types of electrodes exposed along pacemaker housing 15 for delivering electrical stimulation to the patient’s heart and sensing cardiac electrical signals. Electrodes 16 and 18 may be, without limitation, titanium, platinum, iridium or alloys thereof and may include a low polarizing coating, such as titanium nitride, iridium oxide,Atty Ref. No. A0013476W001ruthenium oxide, platinum black, among others. Electrodes 16 and 18 may be positioned at locations along IMD housing 15 other than the locations shown.
[0048] In some examples, electrodes 16 and 18 and / or other electrodes carried by housing 15 may be used as an electrode vector for sending and / or receiving tissue conduction communication (TCC) signals. TCC uses the human body as the medium of communication. TCC may sometimes be referred to as human body conduction (HBC) or intrabody communication. TCC signals may be conducted via body tissue from a transmitting electrode vector of one IMD to a receiving electrode vector of a second IMD for example. As described above, in some examples, IMD 14 may be co-implanted with a second IMD (e.g., cardiac monitor 62 or pacemaker 12 as shown in FIG. 1 as illustrative, non-limiting examples). Two co-implanted IMDs could communicate via TCC. In some cases, IMD 14 could communicate with another external device having TCC electrodes on the patient’s skin. Electrical signal sensing circuitry of IMD 14 may be configured to receive TCC signals from another device. Pulse generating circuitry of IMD 14 may be controlled to generate TCC signals, which may include a carrier signal that is modulated according to a selected modulation method to encode data for transmitting to another device. Modulation of TCC signals may include amplitude, frequency, digital, frequency shift keying and / or phase shift keying as examples. Example methods and devices for performing TCC are generally disclosed in U.S. Patent No. 11,213,684 (Peichel, et al., filed November 29, 2018), incorporated herein by reference in its entirety. Techniques disclosed herein may be used for determining a direction of a respiration vector for detecting inspiration and expiration phases from a signal sensed by IMD 14. IMD 14 may transmit communication signals to indicate to a second device the timing of the sensed inspiration and / or expiration phases in some examples.
[0049] Housing 15 can be formed from a biocompatible material, such as a stainless steel or titanium alloy. In some examples, housing 15 may include an insulating coating.Examples of insulating coatings include parylene, urethane, PEEK, or polyimide, among others. The entirety of the housing 15 may be insulated, with only electrodes 16 and 18 left uninsulated. Electrode 16 may serve as a cathode electrode and be coupled to internal circuitry, e.g., a pulse generator and cardiac electrical signal sensing circuitry enclosed by housing 15, via an electrical feedthrough crossing housing 15. Electrode 18 may be formed as a conductive portion of housing 15 defining a ring electrode that is electricallyAtty Ref. No. A0013476W001isolated from the other portions of the housing 15 as generally shown in FIG. 2. In other examples, the entire periphery of the housing 15 may function as an electrode that is electrically isolated from tip electrode 16, instead of providing a localized ring electrode such as electrode 18.
[0050] Amotion sensor 212 is included in IMD 14 for sensing a signal responsive to changes in the motion of IMD 14 at least due to respiration. For example, sensor 212 may be an accelerometer having at least one sensor element, e.g., a piezoelectric element or micro-electro-mechanical system (MEMS) device, aligned along an axis of the motion sensor 212 for producing an axis signal. The axis signal may vary as IMD 14 is subjected to acceleration forces due to respiration (as well as other patient body motion).
[0051] In examples described herein, motion sensor 212 is a three-dimensional accelerometer having a three sensor elements 40, 42 and 44 aligned orthogonally to each other along three respective orthogonal axes Al, A2 and A3 for sensing acceleration along the respective axis Al, A2 or A3. In some examples, one accelerometer sensor element 42 may be aligned with the longitudinal axis 22 of IMD 14, as indicated by sensor axis A2. The second and third accelerometer sensor elements 40 and 44 may be aligned in radial directions relative to the IMD longitudinal axis 22 and sensor axis A2, as represented by radial axes Al and A3, respectively. In this way, sensor 212 may produce a three-dimensional accelerometer signal having three orthogonal axis signals produced by the respective accelerometer sensor elements 40, 42 and 44. The three axis signals can define a respiration vector having a magnitude and direction relative to motion caused by respiration, as further described below. In other examples, sensor 212 may include one, two, three or more sensor elements, each aligned along a respective sensor axis. In some examples, motion sensor 212 includes six sensor elements positioned along six respective axes to enable IMD 14 to sense both linear and rotational motion. In other examples, an axis of motion sensor 212 need not necessarily be aligned with the longitudinal axis 22 of IMD 14.
[0052] In the illustrative examples presented herein, sensor 212 is provided as an accelerometer configured to produce an acceleration signal along at least a first axis, e.g., axis Al. The acceleration signal may vary cyclically with the respiration cycle as well as the cardiac cycle when implanted on, in or near the heart. The acceleration signal may further vary with patient body motion associated with physical activity or otherAtty Ref. No. A0013476W001acceleration forces that the patient is subjected to. The acceleration signals received from each axis sensor element 40, 42 and 44 may be filtered for obtaining a respiration acceleration signal from each axis. As further described below, a respiration vector representative of the primary motion of respiration may be determined from respiration acceleration signals and used in identifying a respiration phase-dependent feature of a signal sensed by the IMD 14 that can be detected by IMD 14 for sensing respiration phases.
[0053] The acceleration signal along each axis Al, A2 and A3 will include a DC component representative of the alignment of the respective axis with the direction of gravity (G) 23. As the orientation of sensor 212 changes with respect to gravity, the DC or average acceleration signal produced by the sensor elements 40, 42, and 44 of each axis Al, A2 and A3 will vary. For example, when aligned with gravity, the sensor element 40 may produce an average acceleration signal equal to + 9.8 m / s / s (+1 g) or - 9.8 m / s / s (- 1 g). When provided as a three dimensional accelerometer as shown in FIG. 2, each sensor element 40, 42 and 44 senses acceleration projected along the respective axis Al, A2 or A3 such that the average or DC magnitude of the acceleration vector defined by the axis signals of sensor elements 40, 42 and 44 can be equal to +1 g. The component signals of the three dimensional accelerometer can be used by processing circuitry of IMD 14 and / or external device 50 to determine a posture vector that represents the orientation of sensor 212 with respect to gravity. As further described below, the respiration vector corresponding to a primary direction of displacement due to respiration may be different for different posture vectors.
[0054] Each sensor element of a single or multi-dimensional accelerometer may be defined by a piezoelectric element, micro-electrical mechanical system (MEMS) device or other sensor element capable of producing an electrical signal in response to changes in acceleration imparted on the sensor element, e.g., by converting the acceleration to a force or displacement that is converted to the electrical signal. A medical device system operating according to the techniques disclosed herein may determine a respiration vector corresponding to a direction of respiratory motion imparted on the accelerometer provided as the motion sensor 212. The respiration vector may be determined in a three dimensional (3D) space defined by three orthogonal axes of the accelerometer. The IMD 14 may identify the direction of motion along the respiration vector corresponding to inspirationAtty Ref. No. A0013476W001and the opposite direction of motion along the respiration vector corresponding to expiration.
[0055] As further described below, IMD 14 may determine a feature of a signal sensed by IMD 14, which may be sensed by the motion sensor 212 or another signal sensed by IMD 14 such as a cardiac electrical signal, that exhibits a respiration phase-dependent change that occurs as the direction of motion changes along the respiration vector. The phasedependent feature of the sensed signal can be detected by the IMD 14 for sensing the inspiration and expiration phases of the respiratory cycle. Thus enabled for reliably detecting and positively discriminating the phases of the respiratory cycle, IMD 14 is capable of controlling a therapy, e.g., RSA pacing, and / or monitoring for respiration phase-dependent changes in the patient’s respiration that may be indicative of a change in a respiration condition, which may be a pathological condition that requires clinical intervention or other treatment.
[0056] IMD 14 may include a set of fixation tines 36 or other fixation member(s) to secure IMD 14 to patient tissue at the implant site. Fixation tines 36 are configured to anchor IMD 14 to position electrode 16 in operative proximity to a targeted tissue for delivering therapeutic electrical stimulation pulses. Numerous types of active and / or passive fixation members may be employed for anchoring or stabilizing IMD 14 in an implant position. In the distal electrode 16 extending from distal end 26 may be provided in the shape of a tissue piercing helix, fishhook or other shaped electrode to provide an active fixation member, instead of the button type of electrode as shown in FIG. 2. For example, a helical electrode may be rotatably advanced into the cardiac tissue to provide fixation of IMD 14 at the implant site and serve as an electrode for sensing and pacing.
[0057] IMD 14 may include a delivery tool interface 38. Delivery tool interface 38 may be located at the proximal end 28 of IMD 14 and is configured to connect to a delivery tool used to position IMD 14 at an implant location during an implant procedure, for example within a heart chamber. A clinician may rotate, advance and / or retract IMD 14 using the delivery tool connected to IMD 14 via the delivery tool interface 38.
[0058] FIG. 3 is a diagram 200 of an example configuration of an IMD of a medical device system configured to detect the inspiration and expiration phases of respiration cycles according to the techniques disclosed herein. FIG. 3 is described with reference to IMD 14 shown in FIGs. 1 and 2 for the sake of illustration. However, it is to be understoodAtty Ref. No. A0013476W001from this disclosure that the functionality described herein may be implemented in a number of medical device systems having varying hardware, firmware and / or software architecture but includes a motion sensor for sensing respiration motion. Any of the example devices listed above may include circuitry and components configured to perform the functionality attributed to IMD 14 and medical device system 10 of FIG. 1 for sensing respiration phases according to the disclosed techniques.
[0059] IMD 14 may include a pulse generator 202, a cardiac electrical signal sensing circuit 204, a control circuit 206, memory 210, communication circuit 208, motion sensor 212 and a power source 214. The various circuits represented in FIG. 3 may be combined on one or more integrated circuit boards which include an application specific integrated circuit (ASIC), an electronic circuit, a processor (shared, dedicated, or group) and memory that execute one or more software or firmware programs, a combinational logic circuit, state machine or other suitable components that provide the described functionality.
[0060] Motion sensor 212 includes an accelerometer in the examples described herein. Motion sensor 212 is not limited to being an accelerometer, however, and other motion sensors, e.g., a gyroscope or magnetometer or combinations thereof, may be utilized successfully in IMD 14 for determining a respiration vector that can be used in positively identifying a direction of motion during a respiration phase. Motion sensor 212 may be a multi-axis sensor, e.g., a two-dimensional, three-dimensional sensor or six-dimensional sensor, with each axis sensing an axis signal that may be analyzed individually or in combination for determining a respiration vector as one of or a combination of the axis signals. Based on a respiration vector defined by at least one axis signal of motion sensor 212, control circuit 206 (and / or other processing circuitry of the medical device system such as external device processor 52) may determine a sensed signal feature that is respiration phase-dependent and correlated to the direction of motion along the respiration vector during a positively identified inspiration or expiration phase of the respiration cycle.
[0061] Motion sensor 212 may produce an electrical signal correlated to motion or vibration of motion sensor 212 (and IMD 14), e.g., when subjected to acceleration forces of respiration as well as flowing blood (if implanted inside heart chamber or blood vessel), cardiac motion, patient body motion and gravity. As such, in some examples, control circuit 206 may detect cardiac motion signals, patient physical activity metrics, or otherAtty Ref. No. A0013476W001motion related events or metrics using the acceleration signals received from motion sensor 212. Motion sensor 212 may include one or more filter / amplifier 218, rectifier, analog-to-digital converter (ADC) 216 and / or other components for producing an acceleration signal that is passed to control circuit 206. Signals produced by each individual axis Al, A2 and A3 of the multi-axis accelerometer may be filtered by a low pass or band pass filter for selectively providing one or more individual axis signals and / or providing combined axis signal(s) (e.g., a combination of two individual axis signals and / or a combination of all three axis signals) to control circuit 206, which may be digitized by ADC 216. The signal(s) may be further sensed with respective bias and sensitivity applied to each digitized axis, e.g., using gravity as a reference vector. The accelerometer axis signals may be filtered by a 2 Hz, 1 Hz, 0.8 Hz, 0.6 Hz or 0.5 Hz or lower low pass filter to obtain a respiration signal. In an example, with no limitation intended a bandpass filter may be applied to the accelerometer axis signals having an effective passband in the range of 0.05 to 1 Hz or high pass cutoff frequency of 0.05 Hz and a low pass cutoff frequency of 0.4 to 0.6 Hz to obtain a respiration signal from which phase-dependent signal features can be detected for sensing respiration phases. The low pass or bandpass filtered signal sensed by one or more axes of the multi -axis accelerometer may be analyzed for determining a respiration vector and for monitoring for inspiration and expiration phases.
[0062] In some examples, the respiration vector may be determined from accelerometer axis signals having a wider bandpass than the relatively low pass filtered signals used for sensing respiration phases. For example, the acceleration axis signals from which the respiration vector is derived may be determined from 0.1 to 20 Hz or 0.1 to 10 Hz bandpass filtered acceleration signals.
[0063] In some examples, one or more high pass or band pass filtered acceleration signals may be digitized by ADC 216 and rectified for use by control circuit 206 for detecting cardiac event signals and / or determining a patient physical activity metric, which may be used in combination with the techniques disclosed herein for controlling the timing and rate of cardiac pacing pulses. Accordingly, various filtering and / or rectification may be applied to the acceleration signals that are passed to control circuit 206 from motion sensor 212 for the different purposes of deriving a respiration vector for positively identifying directions of inspiration phase motion and expiration phase motion, sensing aAtty Ref. No. A0013476W001respiration signal from which inspiration and respiration phases are sensed from based on phase-dependent signal changes identified during the positively identified inspiration and expiration phases, determining a posture vector, monitoring cardiac motion signals, and / or monitoring patient physical activity.
[0064] Communication circuit 208 may include a transceiver 209 and antenna 211 for transmitting and receiving data, e.g., via a radio frequency (RF) communication link with another device, e.g., as generally described above in conjunction with FIG. 1.Programmable control parameters and algorithms for performing and controlling respiration phase sensing, cardiac signal sensing, cardiac pacing and other functions of IMD 14 may be transmitted to IMD 14 and received by communication circuit 208 and stored in memory 210 for access by control circuit 206. In some examples, communication circuit 208 may be controlled by control circuit 206 to transmit a respiration phase detection signal in timed relation to the detection of a respiration phase-dependent signal feature. The respiration phase detection signal may indicate the timing of a positively identified respiration phase and could indicate the start or end of a sensed respiration phase or an intervening time point during the respiration phase. The respiration phase detection signal could be received by a co-implanted device for use in controlling the timing of performing a phase-dependent respiration monitoring function and / or therapy delivery function.
[0065] IMD 14 may include a sensing circuit 204 configured to receive a cardiac electrical signal via electrodes 16 and 18 by a pre-filter and amplifier circuit 220. Pre-filter and amplifier circuit may include a high pass filter to remove DC offset, e.g., a 2.5 to 5 Hz high pass filter, or a wideband filter having a passband of 2.5 Hz to 100 Hz to remove DC offset and high frequency noise. Pre-filter and amplifier circuit 220 may further include an amplifier to amplify the “raw” cardiac electrical signal passed to analog-to-digital converter (ADC) 226. ADC 226 may pass a multi-bit, digital EGM signal to control circuit 206 for use by processor 244 in identifying ventricular electrical events (e.g., R-waves or T-waves) and / or atrial electrical events, e.g., P-waves. Identification of cardiac electrical events may be used for identifying cardiac cycles and determining a heart rhythm. As further described below, in some examples, a respiration phase-dependent change in a cardiac electrical signal, e.g., peak R-wave amplitude, may be detected for use inAtty Ref. No. A0013476W001positively identifying a direction of respiration motion along the respiration vector derived from the acceleration signal received from sensor 212.
[0066] Sensing circuit 204 may include a cardiac event detector circuit 224 for sensing cardiac event signals attendant to cardiac electrical depolarizations, e.g., P-waves attendant to atrial depolarizations and / or R-waves attendant to ventricular depolarizations. A rectifier / amplifier circuit 22 may amplify and rectify the digital output of ADC 226 that passes the sensed signal to cardiac event detector circuit 224. Cardiac event detector circuit 224 may include a sense amplifier or other detection circuitry that compares the incoming rectified, cardiac electrical signal to a cardiac event sensing threshold, e.g., an R-wave sensing threshold or a P-wave sensing threshold, which may be an auto-adjusting threshold. When the incoming signal crosses the cardiac event sensing threshold, the detector circuit 224 may produce a sensed event signal (e.g., a Vsense signal when the R-wave sensing threshold is crossed or an Asense signal when the P-wave sensing threshold is crossed). The sensed event signal can be passed to control circuit 206 for use in controlling cardiac pacing pulses delivered by pulse generator 202, determining the heart rate and rhythm, and for identifying cardiac cycles. Cardiac event detector circuit 224 or control circuit 206 may receive the digital output of ADC 226 for detecting R-waves and / or P-waves by a comparator, morphological signal analysis of the digital EGM signal or other cardiac event signal detection techniques. Cardiac event detector 224 may include a peak detector for detecting the maximum peak amplitude of a sensed R-wave. For instance, cardiac event detector 224 may include a peak track and hold circuit that determines the maximum peak of the rectified cardiac electrical signal during a peak tracking window that follows an R-wave sensing threshold crossing. The R-wave peak amplitude may be passed to control circuit 206 for use in positively identifying the direction of motion along the respiration vector derived from the acceleration signal received from sensor 212 in some examples.
[0067] Control circuit 206 may include a pace timing circuit 242 and a processor 244. Processor 244 may provide sensing control signals to sensing circuit 204, e.g., cardiac event sensing threshold parameters, sensitivity, and various blanking and refractory intervals applied to the cardiac electrical signal for controlling cardiac event signal sensing. Cardiac sensed event signals passed from detector circuit 224 and / or one or more EGM signals passed from ADC 226 to control circuit 206 may be used for determining theAtty Ref. No. A0013476W001cardiac rate and rhythm and scheduling cardiac pacing pulses by pace timing circuit 242 according to a programmed pacing mode.
[0068] In addition to receiving acceleration signals from motion sensor 212 for use in respiration monitoring, processor 244 may receive acceleration signals from sensor 212 for detecting cardiac mechanical events in some examples. For instance, an accelerometer signal received as a single axis signal or a combination of two or more axis signals from sensor 212 may be analyzed by processor 244 for detecting an acceleration signal waveform attendant to cardiac mechanical events, e.g., ventricular systole and / or atrial systole. In some examples, processor 244 may sense atrial systolic events from an acceleration signal when IMD 14 is implanted in the RV (e.g., as shown in FIG. 1) for triggering an atrial synchronous ventricular pacing pulse. Processor 244 may additionally or alternatively determine a patient activity metric from an acceleration signal received from sensor 212 for determining a sensor indicated pacing rate (SIR) to control pulse generator 202 to deliver rate response pacing pulses at a pacing rate in accordance with the patient’s physical activity level and metabolic need.
[0069] Pace timing circuit 242 may include one or more timers or counters for controlling various pacing escape intervals. For example, pace timing circuit 242 may include a lower pacing rate interval timer for controlling pulse generator 202 to deliver ventricular pacing pulses according to a minimum pacing rate. According to some examples, the ventricular pacing rate may be modulated with sensed inspiration and expiration phases to mimic RSA to provide RSA pacing. When an atrial systolic event signal is sensed from an acceleration signal received from motion sensor 212, pace timing circuit 242 may start an AV pacing interval to control pulse generator 202 to deliver an atrial synchronous ventricular pacing pulse upon expiration of the AV pacing interval.
[0070] In other examples, IMD 14 may be implanted in an atrial location for delivering atrial pacing pulses in which case the pulse generator 202 may be controlled by pace timing circuit 242 to deliver atrial pacing pulses upon expiration of an atrial lower pacing rate interval. The atrial lower pacing rate interval may be adjusted according to a rate response pacing rate determined from a sensor indicated pacing rate derived from a patient activity metric determined from an acceleration signal received from sensor 212. The atrial lower pacing rate may be modulated in response to sensed inspiration and expiration phases to provide RSA pacing. Modulation of the pacing rate to provide RSA pacing mayAtty Ref. No. A0013476W001or may not continue when the pacing rate is increased to a rate response rate to provide increased heart rate during increased patient physical activity.
[0071] Pulse generator 202 generates electrical pacing pulses that are delivered to the patient’s heart, via electrodes 16 and 18, at appropriate timing intervals under the control of pace timing circuit 242. Additional electrodes may be provided in some examples to enable IMD 14 to deliver atrial and / or ventricular pacing pulses. In addition to providing control signals to pace timing circuit 242 and pulse generator 202 for controlling the timing of pacing pulses, processor 244 may retrieve programmable pacing control parameters from memory 210, such as pacing pulse amplitude and pacing pulse width, which are passed to pulse generator 202 for controlling pacing pulse delivery. Pulse generator 202 may include charging circuit 230, switching circuit 232 and an output circuit 234.
[0072] Charging circuit 230 may include a holding capacitor that may be charged to a pacing pulse amplitude by a multiple of the battery voltage signal of power source 214 under the control of a voltage regulator. The pacing pulse amplitude may be set based on a control signal from control circuit 206. Switching circuit 232 may control when the holding capacitor of charging circuit 230 is coupled to the output circuit 234 for delivering the pacing pulse. For example, switching circuit 232 may include a switch that is activated by a timing signal received from pace timing circuit 242 upon expiration of pacing escape interval and kept closed for a programmed pacing pulse width to enable discharging of the holding capacitor of charging circuit 230. The holding capacitor, previously charged to the pacing pulse voltage amplitude, is discharged across electrodes 16 and 18 through the output capacitor of output circuit 234 for the programmed pacing pulse duration.
[0073] In some examples, IMD 14 may be configured to communicate with another medical device via TCC. In this case, IMD 14 may be provided with two or more electrodes that may be selected in a transmitting and / or receiving electrode vector. When IMD 14 is configured to communicate using TCC, pulse generator 202 may be controlled to generate and transmit TCC signals via electrodes 16 and 18 (or other electrodes included on IMD housing 15). TCC signals may be modulated by processor 224 or a modulator that may be included in communication circuit 208. TCC signals transmitted to IMD 14 can be received by electrodes 16 and 18. The received TCC signals may be sensed by sensing circuit 204 and passed to control circuit 206 and / or communication circuit 208Atty Ref. No. A0013476W001for demodulation. TCC signals may be transmitted and received by IMD 14 for coordinating cardiac electrical stimulation therapies with co-implanted medical devices, e.g., pacemaker 12 implanted in the right atrium when IMD 14 is implanted in the right ventricle. TCC signals may be transmitted by IMD 14 to indicate the time of inspiration or expiration phases, for example, when a pacing rate controlled by another IMD, e.g., pacemaker 12, is being modulated to mimic RSA. TCC signals may be transmitted by IMD 14 in timed relation to the inspiration phase detection and / or expiration phase detection (e.g., end inspiration and / or end expiration) to another implanted or external medical device. The transmitted TCC signals may be received by the second medical device for use in controlling a phase-dependent respiration monitoring function and / or a phase-dependent therapy delivery.
[0074] Memory 210 may include computer-readable instructions that, when executed by control circuit 206, cause control circuit 206 to perform various functions attributed throughout this disclosure to IMD 14. The computer-readable instructions may be encoded within memory 210. Memory 210 may include any non-transitory, computer-readable storage media including any volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, or other digital media with the sole exception being a transitory propagating signal. Memory 210 may store data used by control circuit 206 to perform various functions attributed to IMD 14 herein.
[0075] Power source 214 provides power to each of the other circuits and components of IMD 14 as required. Power source 214 may include one or more energy storage devices, such as one or more rechargeable or non-rechargeable batteries. The connections between power source 214 and other pacemaker circuits and components are not shown in FIG. 3 for the sake of clarity but are to be understood from the general block diagram of FIG. 3. For example, power source 214 may provide power as needed to charging and switching circuitry included in pulse generator 202, amplifiers, ADC 226 and other components of sensing circuit 204, communication circuit 208 and motion sensor 212.
[0076] In various examples, IMD 14 may include one or more other physiological sensor(s) 213 for sensing a signal that is used by control circuit 206 for monitoring a physiological condition of the patient and / or controlling electrical stimulation delivered byAtty Ref. No. A0013476W001pulse generator 202. For example, sensor(s) 213 may include one or more of a pressure sensor, temperature sensor, acoustic sensor (such as a microphone or other acoustical sensor for sensing heart sounds, respiration sounds, etc.) or oxygen saturation sensor. Sensor(s) 213 may include an impedance sensor for sensing impedance between electrodes 16 and 18, e.g., by applying a drive signal via pulse generator 202, and sensing the resulting voltage or current signal. In accordance with the techniques disclosed herein, any signal sensed by IMD 14 may be analyzed for detecting a respiration phase-dependent feature of the sensed signal that changes with inspiration and expiration phases. The respiration phase-dependent feature may be identified in timed relation to a respiration phase that is detected based on a direction of motion along a respiration vector determined from an acceleration signal received from motion sensor 212. After identifying the phasedependent feature of the sensed signal, control circuit 206 may subsequently sense respiration phases by detecting the phase-dependent feature for use in controlling a respiration phase-dependent monitoring and / or therapy delivery function.
[0077] The functions attributed to IMD 14 and other HMDs described herein may be embodied as one or more processors, controllers, hardware, firmware, software, or any combination thereof. Depiction of different features as specific circuitry is intended to highlight different functional aspects and does not necessarily imply that such functions must be realized by separate hardware, firmware or software components or by any particular circuit architecture. Rather, functionality associated with one or more circuits described herein may be performed by separate hardware, firmware or software components, or integrated within common hardware, firmware or software components. Providing software, hardware, and / or firmware to accomplish the described functionality in the context of any modern medical device system, given the disclosure herein, is within the abilities of one of skill in the art.
[0078] While one example IMD is described with reference to FIG. 3, e.g., corresponding to IMD 14, it is recognized that a variety of HMDs may be configured to sense respiration phases with a need for confidently discriminating between and positively identifying inspiration and expiration phases. A medical device system configured to perform the techniques disclosed herein is therefore not limited to being a cardiac pacemaker and may be any of the example IMDs listed herein, with no limitation intended.Atty Ref. No. A0013476W001
[0079] FIG. 4 is a flow chart 300 of a method that may be performed by a medical device system for sensing respiration phases according to some examples. At block 302, control circuit 206 may power on the motion sensor 212 (if not already enabled) for sensing a motion signal over one or more respiration cycles. The motion sensor signal, which is also referred to hereafter as an “acceleration signal” or “accelerometer signal” for the illustrative examples presented herein when motion sensor 212 is embodied as an accelerometer, may be passed to control circuit 206 for determining a respiration vector. The acceleration signal may be sensed for 1 to 100 respiration cycles or 3 to 20 respiration cycles, as examples. The number of respiration cycles may be counted by control circuit 206 by detecting the peaks and / or troughs of the acceleration signal that are occurring at an expected respiration rate, e.g., 6 to 20 breaths per minute. Detection of the peaks and troughs, however, may not be indicative of which phase of respiration is starting or ending, however, because the sensor orientation may be unknown resulting in respiration motion occurring in each axis of the accelerometer in unpredictable or unknown patterns. Furthermore, due to various disease states or pathological conditions, cyclical changes in the acceleration signal may not conform to normal or predictable patterns or characteristics that are expected with the respiration cycle in a normal patient. The acceleration signal may be received for a specified time period expected to encompass a desired number of respiration cycles, e.g., at least 30 seconds, one minute, two minutes, five minutes or 10 minutes. In other examples, the acceleration signal may be received for a specified number of cardiac cycles which may be counted based on sensed P-waves, sensed R-waves and / or delivered cardiac pacing pulses. For instance, control circuit 206 may receive the acceleration signal over at least 40, 60, 90, 120, 200, 500 or 1000 cardiac cycles as examples. The digitized axis signals received from each axis Al, A2 and A3 of motion sensor 212 may be buffered in memory 210 as needed for subsequent processing and analysis.
[0080] At block 304, control circuit 206 may determine a respiration vector from the received acceleration signal. For the sake of example, a three dimensional acceleration signal may be received including an axis signal from each of the Al, A2 and A3 axes as shown in FIGs. 2 and 3. In other examples, a one dimensional or two dimensional acceleration signal could be received. However, when the primary direction of respiration motion (e.g., greatest displacement or highest acceleration) is perpendicular to a singleAtty Ref. No. A0013476W001accelerometer axis vector, the sensitivity for detecting respiration cycles may be reduced. In other examples, the motion signal may be received from motion sensor 212 having more than three individual sensor elements as shown here. In an example, motion sensor 212 may include up to six sensor elements to provide linear acceleration along each Al, A2 and A3 axis as well as angular rotation about each Al, A2 and A3 axis, or up to nine sensor elements with integrated magnetic sensing, so that directions of linear and rotational motion with respect to each Al, A2 and A3 axis can be determined. In this way, a respiration vector can be determined from the linear and rotational vector components that is representative of the primary direction of motion during inspiration and expiration phases. In other examples, motion sensor 212 may include sensor elements, e.g., gyroscopes, for sensing rotational motion around one or more sensor axes that can be used in determining a respiration vector when rotational motion of the motion sensor 212 due to respiration is the primary motion during respiration as opposed to translation or linear motion.
[0081] Motion imparted on motion sensor 212 and IMD 14, e.g., due to cyclic motion of the lungs, diaphragm, etc. and cyclic motion of the patient’s heart (when implanted in or near the heart), can be tracked by calculating an absolute position of motion sensor 212 at multiple time points during each of the phases of inspiration or expiration. In an illustrative example, with reference to a 3D accelerometer of motion sensor 212, a 3D respiration vector may be determined at block 304 by determining a displacement signal from the acceleration signal and determining sample points (x(t), y(t), z(t)) at each time point according to a desired sampling rate (e.g., 128 Hz, 256 Hz, 512 Hz or higher) through one or more respiration cycles. Control circuit 206 may determine or approximate the second integral of each axis signal to obtain a three dimensional displacement (or position) signal corresponding to the position of the accelerometer in a local coordinate system over multiple respiration cycles. The displacement (or position) coordinates may be determined by dead reckoning using an initial 3D position sample point as a nominal starting point and determining the position or displacement from the starting point at the next time point using the 3D acceleration sample point (al(t), a2(t), a3(t)) at the next time point, where al(t) is the amplitude of the Al axis acceleration signal at time t, a2(t) is the amplitude of the A2 axis acceleration signal at time t and a3 is the amplitude of the A3 axis acceleration signal at time t. The integration of the acceleration signal may beAtty Ref. No. A0013476W001performed by summing the consecutive sample points (approximating the area), applying the trapezoidal rule, Simpson’s rule or other digital signal processing techniques for determining or approximating the integral of the digitized acceleration signal to obtain a displacement signal defined by (x(t), y(t), z(t)) sample points. In other examples, the displacement signal may be determined from the acceleration signal as a lowpass filtered and smoothed signal. The starting point along the respiration vector determined as a displacement vector representative of primary directions of motion during respiration may be the time point of minimum or maximum peak of the acceleration waveform or at zero acceleration which may correspond in time to the end of inspiration and start of expiration or the end of expiration and the start of inspiration.
[0082] Control circuit 206 may determine the maximum excursion of the motion sensor 212 in each x, y and z direction of the local coordinate system from the 3D displacement signal. For instance, the respiration vector, R, may be expressed as (xmax-xmin, ymax-ymin, zmax-zmin) where the maximum and minimum x, y and z coordinates may be determined from the three dimensional displacement signal as the two (x(t), y(t), z(t)) displacement signal sample points that occur at a maximum distance apart during at least one respiration cycle.
[0083] For instance, the distance from a starting point may be determined for each (x(t), y(t), z(t)) sample point of the displacement signal using vector math. The time point, tmax, that the maximum excursion from a starting point occurs may be identified so that the maximum displacement (x(tmax), y(tmax), z(tmax)) in a first direction can be determined as a first end point of the respiration vector. The time point, tmin, that the minimum displacement occurs may be identified so that the minimum displacement (x(tmin), y(tmin), z(tmin)) can be determined as a second end point of the respiration vector. In some examples, the starting time point may be identified as the end of expiration and defined as zero displacement such that the maximum displacement occurs at the end of inspiration though other conventions may be used. The respiration vector, R, may extend from an origin of the 3D local coordinate space to the point of maximum displacement at the end of inspiration in one example.
[0084] It is contemplated that, in other examples, a respiration vector may be determined as a 3D acceleration vector extending between the maximum acceleration and minimum acceleration of the 3D acceleration signal. In still other examples, the respiration vectorAtty Ref. No. A0013476W001may be determined as a velocity vector extending between a maximum velocity and a minimum velocity of a 3D velocity signal determined as the first integration of the 3D acceleration signal. Because the direction of motion during a respiration cycle represented by the direction of displacement or position during the respiration cycle may be more intuitive to a clinician or other user than a respiration vector represented as an acceleration vector or a velocity vector, the respiration vector may be determined as the displacement or position vector extending between a point of maximum displacement during the respiration cycle and a starting point or between a point of maximum displacement and a point of minimum displacement from a nominal starting point during the respiration cycle.
[0085] Having determined the respiration vector R as a representation of the directions of motion over at least one respiration cycle, control circuit 206 may positively identify (at block 306) the direction of motion along the respiration vector when inspiration is occurring and / or the direction of motion along the respiration vector when expiration is occurring (opposite the direction of positional change during inspiration). Control circuit 206 may receive an orienting input signal at block 305 that can be used for positively identifying the direction of motion along the respiration vector at a given time point that corresponds to a specified respiration phase based on the orienting input signal. The orienting input signal (also referred to herein as “orienting input”) may be received for one or more respiration cycles and may be received for only the inspiration phase, only the expiration phase, or both inspiration and expiration phases. Control circuit 206 may receive the orienting input as a timing marker indicating the start time, end time and / or one or more intervening time points that occur between the start and end times of a given respiration phase. The orienting input may be thought of as a respiration phase timing input that control circuit 206 receives in timed relation to a given respiration phase such that the direction of motion, e.g., displacement, along the respiration vector from a current sample point (or relatively earlier sample point) to a relatively later sample point can be positively identified as the direction of positional change or motion along the respiration vector during the given respiration phase.
[0086] In some examples, the orienting input can be a communication signal received by IMD communication circuit 208. The communication signal may be transmitted by another medical device, e.g., external device 50 or another co-implanted medical device (e.g., cardiac monitor 62 shown in FIG. 1). The communication signal may be transmittedAtty Ref. No. A0013476W001by external device 50, for instance, in response to the patient or another user manually inputting a timing marker (e.g., via user interface 56) indicating the start time, end time or a time point during a given respiration phase.
[0087] In other examples, external device 50 may be configured to receive a signal from an orienting signal source 60 (see FIG. 1). In some instances, the orienting signal source 60 may be a ventilator controlling the patient’s respiration. The ventilator may transmit one or more timing markers to external device 50 indicating the time of a specified respiration phase during one or more respiration cycles. External device 50 may receive the timing marker from orienting signal source 60 that indicates the start time, end time or a time point during a specified respiration phase. External device 50 may transmit, via telemetry unit 58, the timing marker received from orienting signal source 60 as the orienting input signal received by control circuit 206 at block 305 for positively identifying the respiration phase corresponding to a direction of motion along the respiration vector.
[0088] In other examples, orienting signal source 60 may be a sensor or medical monitor that is sensing a signal that varies cyclically with respiration. External device 50 may receive the signal from orienting signal source 60 and detect respiration phases from the signal. Additionally or alternatively, external device 50 may receive a timing marker signal from orienting signal source 60 indicating a time relative to a specified respiration phase detected by orienting signal source 60. Signals that may vary cyclically with respiration that may be sensed by orienting signal source 60 include a surface ECG signal (e.g., cyclical variation of R- wave peak amplitudes can occur with respiration), blood oxygen signal (e.g., from a pulse oximeter), plethysmograph signal, chest impedance signal that varies cyclically with lung volume, or an external motion sensor signal (e.g., from an external accelerometer or other motion sensor positioned on the patient’s chest or abdomen).
[0089] External device processor 52 may receive a signal from orienting signal source 60 and detect a trough, peak, zero crossing, slope, area, signal width or other signal feature that is respiration phase-dependent and can be reliably detected as an indication of the start time, end time or an intervening time point of a given respiration phase. External device processor 52 may generate a timing marker indicating the detected start time, end time or intervening time point of the given respiration phase that can be transmitted by telemetryAtty Ref. No. A0013476W001unit 58 to IMD 14 as the orienting input signal received by control circuit 206 at block 305.
[0090] In an illustrative example, external device 50 may be coupled to ECG electrodes positioned on the patient provided as the orienting signal source 60 (shown in FIG. 1). External device processor 52 may detect cyclical variation of R- wave peak amplitude from the ECG signal that corresponds to the normally expected decrease in R-wave peak amplitude during inspiration and increase in R-wave peak amplitude during expiration. External device processor 52 may generate a timing marker indicating the start time, end time and / or one or more intervening time points during a specified respiration phase (e.g., inspiration or expiration) for transmission by telemetry unit 58 to IMD 14. The timing marker signals may be transmitted for one or more respiration cycles as the orienting input received by control circuit 206 at block 305.
[0091] Control circuit 206 may receive the orienting input via communication circuit 208 and determine a time aligned displacement signal sample point from the acceleration axis signals. Control circuit 206 may determine a direction of motion along the respiration vector from the displacement signal sample point obtained at the time of the received orienting input to a later (and / or earlier) displacement signal sample point to identify the direction of motion between the two sample points as the direction of motion for the given respiration phase (e.g., inspiration or expiration). It is recognized that cardiac motion or other body motion may cause higher frequency “wiggles” and other variation in the displacement signal. A primary direction of respiration motion along the respiration vector, however, from the time of a timing marker of the orienting input to one or more later (and / or earlier) displacement signal sample points may be derived from the acceleration signal received from IMD sensor 212, which may be a low pass filtered or integrated to determine a displacement signal.
[0092] In other examples, the orienting input may be received by control circuit 206 at block 305 from a co-implanted device that is sensing a signal that varies cyclically with the respiration cycle. The communication signal transmitted by the co-implanted device as the orienting input may be transmitted to IMD communication circuit 208 or transmitted as a TCC signal, e.g., received by IMD electrodes 16 and 18 and detected by sensing circuit 204, instead of or in addition to a communication signal received via communication circuit 208. A co-implanted device, for example, may sense a signal thatAtty Ref. No. A0013476W001varies with the respiration cycle from which a signal feature can be detected as a reliable indication of a given respiration phase. For example, a subcutaneously or submuscularly implanted cardiac monitor 62 (see FIG. 1) may be configured to sense a subcutaneous ECG signal, oxygen saturation signal, impedance signal, acceleration or other motion signal, acoustical signal or other physiological signal that includes predictable, cyclical signal features corresponding to the start, end or intervening time points of a given respiration phase. The co-implanted device may detect the respiration phases from the sensed physiological signal and transmit a communication signal via TCC to IMD 14 for receipt by control circuit 206 as the orienting input at block 305.
[0093] In still other examples, control circuit 206 may receive the orienting input at block 305 as a physiological signal or signal feature sensed by sensing circuit 204 or by motion sensor 212 or by sensor(s) 213 (see FIG. 3) from which control circuit 206 may positively determine the respiration phase. In some patients, a feature of a sensed cardiac electrical signal or a feature of a sensed acceleration signal, for example, may reliably indicate a given respiration phase. For instance, in some patients, the maximum acceleration may occur during inspiration during a majority of respiration cycles. In some instances, the minimum R-wave peak amplitude may occur during inspiration during a majority of respiration cycles. In other examples, pressure, temperature, sounds, oxygen saturation or other signals sensed by physiological sensor(s) 213 may vary predictably with respiration cycle in some patients. As such, in some examples, control circuit 206 may determine a timing marker from a signal sensed by IMD 14 that corresponds to the start time, end time or an intervening time point of a given respiration phase. Control circuit 206 may determine the displacement signal sample point corresponding in time to the timing marker and determine the direction of motion along the respiration vector from the timing marker to one or more later (and / or earlier) sample points of the displacement signal. This determined direction of motion can be positively identified by control circuit 206 as the direction of motion along the respiration vector for the given respiration phase.
[0094] It is recognized, however, that maximum acceleration slope, R-wave peak amplitude, or other signal features that may normally be a reliable indication of respiration phase in a healthy patient for a known orientation of IMD 14 relative to the patient’s anatomy may not be reliable indicators of respiration phase in all patients all of the time due to unknown orientation of IMD 14 relative to the patient anatomy, signal variability,Atty Ref. No. A0013476W001patient pathological conditions or comorbidities and / or other factors. As such, in some examples, the direction along the respiration vector corresponding to inspiration and the opposite direction of motion corresponding to expiration may be truthed by a clinician, patient or other user providing orienting input signal(s) at block 305 to positively indicate the timing of expiration and / or inspiration. For example, the patient or another user may provide an input signal via user interface 56 of external device 50 indicating the start time, end time or an intervening time point of a given respiration phase for one or more respiration cycles that can be received by control circuit 206 to use in combination with a sensed signal feature for positively identifying the respiration phase (e.g., inspiration) corresponding to a first direction of motion along the respiration vector. The opposite direction of motion along the respiration vector can be positively identified as the other respiration phase (e.g., expiration).
[0095] In some examples, instead of providing a user-entered input via user interface 56, the patient may be instructed to perform a breath hold at the end of a specified respiration phase. For example, the patient may be instructed to perform a breath hold for a specified duration, e.g., number of seconds, at the end of inspiration or at the end of expiration. In other examples, the patient may be instructed to perform a breath hold for a first period of time, e.g., a specified number of seconds, at the end of inspiration and a second period of time (different than the first period of time) at the end of expiration. Control circuit 206 may detect the pause in respiration at the end of a specified respiration phase corresponding to the specified breath hold duration. The breath hold may be detected by control circuit 206 by detecting substantially no change (e.g., a plateau) in the displacement signal that extends for the specified breath hold duration. Control circuit 206 may identify a direction of motion along the respiration vector from the displacement signal from the time point of the specified breath hold duration to one or more subsequent time points (all expected to occur within the same respiration phase after the breath hold, e.g., within 1 second from the breath hold). The identified direction of motion along the respiration vector can be positively identified as the next respiration phase after the instructed breath hold with the opposite direction of motion being the respiration phase that occurs prior to the instructed breath hold.
[0096] As such, the respiration phases for each direction of motion along the respiration vector may be positively identified at block 306 by control circuit 206 during an orientingAtty Ref. No. A0013476W001process when the patient is instructed to breathe in, breathe out, and / or perform breath holds. It is noted that control circuit 206 may store the acceleration signal as it is sensed with timing markers indicating detected breath holds (and / or other received timing markers) in memory 210. Subsequently, control circuit 206 can positively identify the direction of motion along the respiration vector during the inspiration and expiration phases using the stored timing markers indicating the start time, end time and / or intervening time points of a given respiration phase identified based on a detected breath hold duration (and / or other orienting input signals), for example.
[0097] After positively identifying the direction of motion along the respiration vector for each respiration phase, control circuit 206 may advance to block 308 to identify one or more phase-dependent signal features that can be subsequently used for sensing respiration phases. Control circuit 206 may sense respiration phases by detecting a signal feature that meets a specified threshold, range or other criteria as an “identified phase-dependent signal feature” that occurs during or at the start or end of a given respiration phase and is therefore a reliable indicator for positively detecting the given respiration phase.
[0098] In order to identify a phase-dependent signal feature for respiration phase sensing, control circuit 206 may analyze one or more signals sensed by IMD 14 at block 308 (e.g., a cardiac electrical signal sensed by sensing circuit 204, the acceleration signal from motion sensor 212, a velocity signal or other signal derived from the acceleration signal, and / or any signal sensed by sensor(s) 213) to identify one or more signal features that correspond to the positively identified inspiration phase and / or expiration phase. As such, the phase-dependent signal features identified at block 308 for sensing respiration phases may or may not be identified from the acceleration signal sensed by motion sensor 212.
[0099] Features of an acceleration and / or velocity signal, however, may be meaningfully linked to specific phases of respiratory motion in both magnitude and direction. The absolute magnitude of acceleration or rectified acceleration signals may be identified as phase-dependent signal features in some examples. An acceleration signal feature that may be identified as a respiration phase-dependent signal feature at block 308 may be a maximum peak, minimum peak, a peak slope (e.g., maximum (positive) slope or minimum (negative) slope), positive to negative zero or other threshold crossing, negative to positive zero or other threshold crossing, area between zero or other threshold crossings, maximum peak magnitude of rectified signal, positive or negative rate change in magnitude, or otherAtty Ref. No. A0013476W001feature of the raw acceleration signal or filtered and / or rectified or otherwise processed signal derived therefrom. The signal feature may be identified from a low pass filtered acceleration signal, an nth order difference signal determined from the acceleration signal, or the derived velocity signal or displacement signal. The phase-dependent signal feature may be identified from a single axis signal of the motion sensor 212 or a combination of two or more axis signals of the motion sensor 212. When the motion sensor 212 includes more than three sensor elements arranged along more than three axes and / or sensor elements, e.g., for sensing both linear and rotational motion, the phase-dependent signal feature may be identified from one or any combination of the multiple sensor element signals.
[0100] Because of the unknown orientation of the motion sensor axes relative to the patient’s anatomy and signal variability due to cardiac and other patient body motion, the phase-dependent signal feature identified as corresponding to a positively identified respiration phase may not be readily apparent or discernable to a user or clinician viewing the acceleration signals. The phase-dependent signal feature that is identified at block 308 may vary between patients and may be identified by analyzing the three single axis acceleration signals, one or more combinations of two axis signals and / or the combination of all three axis signals in order to identify the axis signal or combination of axis signals having at least one phase-dependent signal feature that can be detected by control circuit 206 for reliably sensing and discriminating between the respiration phases. For example, control circuit 206 may identify a phase-dependent signal feature, such as maximum peak amplitude, minimum peak amplitude, maximum slope, or area between zero crossings, with no limitation intended, that varies by at least a specified percentage, e.g., at least 20%, between inspiration and expiration phases so that a reliably detectable change in the signal feature can detected by control circuit 206 for sensing respiration phases. It is noted that the identified phase-dependent signal feature may be detected or meet a specified threshold at a start time, end time or intervening (between start and end) time of a given one of the inspiration phase or expiration phase.
[0101] In other examples, one or more phase-dependent signal features identified at block 308 may be identified from a signal sensed by IMD 14 that is not received from the motion sensor 212. For example, the maximum peak amplitude of R-waves sensed by sensing circuit 204 from a given sensing electrode vector may fluctuate with respiration.Atty Ref. No. A0013476W001Control circuit 206 may determine the maximum peak amplitude of R- waves sensed by sensing circuit 204 during inspiration phases and during expiration phases positively identified based on the determined directions of motion along the respiration vector during the inspiration and expiration phases. As described above, sensing circuit 204 may include a peak track and hold circuit or other circuitry for detecting the maximum peak amplitude of the R-wave after an R-wave sensing threshold crossing. The peak amplitude of the sensed R-wave signal may be passed to control circuit 206. Control circuit 206 may determine the maximum, median, average or range of peak amplitudes of the sensed R-wave signal during inspiration and during expiration. Based on the difference or separation of the R-wave peak amplitudes during inspiration and expiration, control circuit 206 may establish a threshold amplitude or threshold range that can be applied to maximum peaks of sensed R-wave signals for sensing and positively discriminating between inspiration and expiration phases.
[0102] Any signal sensed by IMD 14 that varies in amplitude, slope, frequency or other characteristic over a respiration cycle such that the cyclical variation of a signal feature can be characterized for the positively identified inspiration and / or expiration phases can be used by control circuit 206 for subsequently sensing inspiration and expiration phases. Other examples of signals that may be sensed by IMD 14 (e.g., by sensor(s) 213 shown in FIG. 3) that have a signal feature that characteristically varies with inspiration and expiration phases may include impedance, pressure, oxygen, temperature, or acoustic signals such as heart sounds or respiration sounds sensed using a microphone or other acoustical sensor. The phase-dependent signal feature may be characterized by control circuit 206 by analyzing the sensed signal during the positively identified phases of respiration based on the detected direction of motion along the respiration vector during one or more respiration cycles. Control circuit 206 may determine a threshold that can be applied to the characterized phase-dependent signal feature for discriminating between inspiration and expiration phases. The determined threshold may be applied to the signal feature for detecting respiration phases during subsequent respiration monitoring and therapy control as further described below.
[0103] At block 310, control circuit 206 senses respiration phases by monitoring at least one signal sensed by IMD 14 for determining the phase-dependent signal feature(s) identified at block 308 and detecting when the phase-dependent signal feature is detected,Atty Ref. No. A0013476W001e.g., when the signal feature meets a threshold, range, trend or other requirement for detecting a corresponding respiration phase. Control circuit 206 may generate a timing marker or other control signal upon detecting each inspiration phase, each expiration phase or both as needed for controlling a phase-dependent respiration monitoring and / or therapy delivery function. The respiration phases may be sensed by control circuit 206 on a breath by breath basis, continuously or intermittently, or less frequently as needed for the particular respiration monitoring and / or therapy delivery function being performed by IMD 14 or the medical device system 10.
[0104] At block 312, control circuit 206 may perform a respiration phase-dependent function in accordance with the sensed respiration phases. For instance, control circuit 206 may determine a phase-dependent respiration metric and / or control a phase-dependent therapy delivered by IMD 14. Control circuit 206 may be sensing the respiration phases to enable processor 244 to determine a respiration metric from a specific phase of a respiration signal. For instance, in some patients, monitoring the duration of the inspiration phase and / or the duration of the expiration phase may be performed for detecting prolonged or shortening of a respiration phase as an indication of worsening of a disease state or a new disease state or condition. Shortness of breath, irregular breathing patterns, changes in breathing effort, or other respiratory changes may be detected by determining inspiration phase metrics and / or expiration phase metrics. Phase-dependent respiration metrics may be determined and stored in memory 210 with a time stamp and / or other relevant information. If a threshold change or a concerning trend in a phase-dependent respiration metric is detected by control circuit 206 at block 312, control circuit 206 may control communication circuit 208 to transmit a notification signal, e.g., to external device 50 (FIG. 1), increase the frequency of determining respiration metrics, and / or enable, stop or adjust a therapy being delivered by IMD 14 in response to the detected change.
[0105] Additionally or alternatively, control circuit 206 may monitor inspiration and expiration phases for providing therapy delivery in timed relation to respiration cycles, such as RSA pacing, electrical stimulation for treatment of sleep apnea or other breathing disorders, electrical stimulation of nerves including the autonomic nervous system, or other phase-dependent therapy delivery. For instance, a rate of electrical stimulation pulses delivered to the heart or a nerve by pulse generator 202 may be varied with respiration phase. In some examples, a phase-dependent therapy being delivered by the medicalAtty Ref. No. A0013476W001device system 10 may be delivered by a co-implanted device rather than by IMD 14. In this case, IMD 14 may transmit a respiration phase detection signal in response to detecting respiration phases on a breath by breath or less frequent basis. A co-implanted medical device may receive the transmitted signal and deliver, stop or adjust a therapy being delivered by the co-implanted device according to respiration phase based on the received respiration phase detection signal.
[0106] FIG. 5 is a flow chart 350 of a method that may be performed by a medical device system for sensing respiration phases according to another example. The respiration vector that is representative of the primary direction of motion caused by respiration may change with changes in patient posture. The IMD 14 may be configured to store a respiration vector determined for two or more different patient postures. The actual posture or position of the patient relative to gravity need not necessarily be known or identified (e.g., supine, upright, side lying left, side lying right, etc.). Rather, for two or more different posture vectors each defined by respective DC components of the Al, A2 and A3 axis signals, respective respiration vectors may be identified and stored in memory 210. The actual patient posture corresponding to the posture vectors need not necessarily be known. For each respiration vector stored for a respective posture vector, however, a corresponding phase-dependent signal feature may be identified for use in sensing and discriminating respiration phases.
[0107] At block 352, control circuit 206 receives the accelerometer signal sensed by motion sensor 212. At block 353, control circuit 206 may determine a posture vector from the accelerometer signal. The posture vector may be defined by the DC components of each of the individual axis signals. The DC component of the three individual axis signals will vary as the patient posture or position changes relative to gravity. The sum of the DC components of the three axis signals, however, is equal to gravity (e.g., within calibration error). As such, control circuit 206 may determine a posture vector at block 353 that corresponds to the current patient posture relative to gravity. The current patient posture may be unknown, because the orientation of motion sensor 212 relative to the patient anatomy can be unknown, but is not required because the respiration vector and a corresponding phase-dependent signal feature identified for respiration phase sensing and discrimination can be determined corresponding to the posture vector without necessarily knowing how the patient is actually positioned (e.g., standing, lying down, etc.).Atty Ref. No. A0013476W001
[0108] In some examples, the patient may be instructed to assume a first posture at the start of the process of flow chart 350. Optionally, the patient or another user may transmit a signal to IMD 14 via external device 50 confirming that the patient is in a stable posture for respiration vector determination. In other examples, control circuit 206 may determine that the posture is stable and unchanging at block 353 based on the DC components of the accelerometer axis signals and determine the respiration vector when the posture vector is determined to be stable and unchanging. If a change in the posture vector is detected, control circuit 206 may suspend the respiration vector determination and restart the process of determining the respiration vector the next time the posture vector is detected and determined to be stable.
[0109] At block 354, control circuit 206 may determine a respiration vector associated with the determined posture vector. The respiration vector can be determined by control circuit 206 according to the example methods described above in conjunction with FIG. 4. The respiration vector may be stored in memory 210 in association with the posture vector determined at block 353. At block 355, control circuit 206 may receive an orienting input used for determining the direction of motion along the respiration vector according to any of the examples given above in conjunction with FIG. 4.
[0110] At block 356, control circuit 206 may determine a respiration phase-dependent signal feature that can be distinctly characterized during the inspiration phase and / or expiration phase identified by the positively determined direction of motion along the respiration vector corresponding to inspiration or expiration during one or more respiration cycles. One or more signal features may be determined at block 356 according to any of the examples described above in conjunction with FIG. 4. Control circuit 206 may identify a feature of a signal sensed by IMD 14 that undergoes a detectable change between inspiration and expiration phases of respiration. Control circuit 206 may establish a threshold or range that the signal feature meets when a given phase of respiration is starting or occurring. The one or more phase-dependent signal features and any established thresholds or ranges corresponding to a respective respiration phase may be stored in memory 210 with the associated first posture vector (and optionally first respiration vector).[oni] At block 358, control circuit 206 may determine if a respiration vector is required for another posture vector. For example, control circuit 206 may be configured toAtty Ref. No. A0013476W001determine a respiration vector for at least two different posture vectors, at least three different posture vectors, or four or more posture vectors. For example, the patient may be instructed to assume a second posture after a specified time interval or after IMD 14 transmits a notification that the process for establishing the respiration vector and phasedependent signal feature for the first posture vector is complete. Optionally, the patient or another user may transmit a signal to IMD 14 via external device 50 confirming that the patient is in the second posture for second respiration vector determination. In other examples, control circuit 206 may detect a second, stable posture at block 353 based on the DC components of the accelerometer axis signals and determine that a respiration vector has not yet been stored in association with the second posture vector, that is different than the first posture vector.
[0112] At block 354, control circuit 206 may determine the second respiration vector associated with the second posture vector. Control circuit 206 may determine, at block 356, if the same phase-dependent signal feature(s) and / or corresponding thresholds or ranges applied to the phase-dependent signal feature(s) determined for the first posture vector can be used to discriminate between inspiration and expiration phases when the second posture vector is being detected. In some cases, the same signal feature(s) and corresponding threshold(s) or range(s) established for sensing inspiration and / or expiration phases for the first posture vector may be used to reliably sense respiration phases during time periods that the second posture vector is being detected. In other cases, at least one phase-dependent signal feature that is different than the phase-dependent signal feature(s) determined for the first posture vector may be identified at block 356 for reliably sensing respiration phases during periods that the second posture vector is being detected. In other examples, the same phase-dependent signal feature may be identified at block 356 for reliably sensing respiration phases during time periods that either the first or the second posture vector is detected, but a second threshold or second range may be identified for applying to the same phase-dependent signal feature for sensing respiration phases when the second posture vector is detected that is different the first threshold or first range determined for applying to the same phase-dependent signal feature when the first posture vector is being detected.
[0113] The process of detecting different patient posture vectors at block 353 defined by respective DC axis signal components can be repeated for a specified number of patientAtty Ref. No. A0013476W001postures. In other examples, control circuit 206 may detect multiple vectors with no limit on the maximum number of posture vectors that can be stored in memory 210 with different respective phase-dependent signal features and / or thresholds or ranges applied to the phase-dependent signal features to be used by control circuit 206 for sensing respiration phases during time periods that the respective posture vector is being detected. For each of the multiple patient posture vectors, control circuit 206 may determine a respective respiration vector at block 354. For each of the patient posture vectors and respective respiration vectors, control circuit 206 may determine at least one phasedependent signal feature and a corresponding threshold or range that can be applied to the signal feature for detecting and discriminating between the inspiration and expiration phases. In some cases, control circuit 206 may determine that one respiration vector and / or common phase-dependent signal feature(s) and thresholds / ranges / criteria applied to detect the phase dependent signal feature(s) may be reliable for subsequent respiration phase sensing for all or multiple posture vectors. In this case, control circuit 206 may bypass posture vector detection during subsequent respiration phase sensing as described below in conjunction with FIG. 6.
[0114] When the process of identifying posture vectors and determining respiration vectors and corresponding phase-dependent signal features for sensing respiration for two or more different patient postures is completed (“no” branch of block 358), control circuit 206 may sense respiration phases at block 360 as needed for a particular monitoring and / or therapy delivery application. Control circuit 206 may detect the patient posture at block 360 and sense the inspiration phase and / or the respiration phase using the phase-dependent signal feature(s) and respective threshold(s) or range(s) determined at block 356 for the detected patient posture. Control circuit 206 may select which signal feature(s) and respective threshold(s) or range(s) are applied to the signal feature(s) at block 360 by determining the posture vector and retrieving from memory 210 the associated signal feature(s) stored (previously at block 356) for the currently detected posture vector.Example methods for sensing respiration phases in combination with detecting posture vectors and monitoring for posture changes are described below in conjunction with FIG.6.
[0115] At block 362, control circuit 206 may perform a respiration phase-dependent function. For example, control circuit 206 may determine a phase-dependent respirationAtty Ref. No. A0013476W001monitoring metric using the sensed respiration phases in accordance with a programmed monitoring protocol. For example, inspiration duration, expiration duration, the peak acceleration during inspiration, peak acceleration during expiration, area of the signal (e.g., area of the displacement curve during inspiration and / or during expiration), and / or other phase-dependent respiration metrics may be determined by control circuit 206 at block 362.
[0116] Additionally or alternatively, control circuit 206 may control a phase-dependent therapy delivered by IMD 14. For example, control circuit 206 may control the rate of cardiac pacing pulses to vary between inspiration and expiration phases to mimic normal RS A. In some examples, IMD 14 may be configured to deliver an electrical stimulation therapy that varies in rate or frequency, for example, between inspiration and expiration phases. For example, a respiration-phase dependent electrical stimulation therapy may be delivered to treat a breathing disorder or a heart rate disorder.
[0117] At block 364, control circuit 206 may determine if an update to the respiration phase sensing parameters is needed. Control circuit 206 may be configured to return to block 352 to repeat the process of detecting different posture vectors and determining the respiration vector and corresponding respiration phase-dependent signal features for each respective posture vector on a scheduled basis, e.g., once per day, once per week, once per month, bi-monthly, etc. Changes in IMD orientation relative to the patient anatomy and primary direction of respiration motion may occur over time. As such, control circuit 206 may return to block 352 to repeat the process of blocks 352 through 358 on a scheduled basis.
[0118] In other examples, control circuit 206 may detect a triggering condition at block 364 for triggering updates of the respiration vectors and / or selections of phase-dependent signal features and / or the thresholds or ranges applied to the phase-dependent signal features for sensing respiration phases. A triggering condition may be a threshold change in a respiration monitoring metric, a change in the trend of the respiration monitoring metric, increased variability in a respiration monitoring metric, or a command signal received by communication circuit 208 (e.g., transmitted by a user interacting with external device 50). For example, a clinician or other user may notice that a phasedependent therapy is being delivered out of phase with the desired respiration phase or opposite in phase with the desired respiration phase. For instance, if RSA pacing is beingAtty Ref. No. A0013476W001delivered by IMD 14, a user may notice that the modulated pacing rate is increasing during expiration and decreasing during inspiration, opposite in phase from the desired variation of pacing rate. The user may enter a command via user interface 56 for transmission to IMD 14 to trigger an update of the respiration vectors and identification of phase-dependent signal features so that respiration phase sensing can be corrected and synchronization of the phase-dependent therapy with respiration phases can be restored.
[0119] A triggering condition detected at block 364 may be detection of a posture vector that does not match any stored posture vectors for which phase-dependent signal features have been identified and stored. In this case, the respiration vector and phase-dependent signal feature(s) for the new posture vector may need to be determined and stored in memory 210. Atriggering condition detected at block 364 may be an inability to detect a respiration phase for a specified time period or number of cardiac cycles or respiration cycles. For instance, the phase-dependent signal feature(s) may not reach an established threshold or range for a given posture vector for detecting inspiration or expiration for one or more respiration cycles or a specified time period. When the phase-dependent signal feature(s) selected for sensing respiration phases for a given posture vector are not meeting the established threshold(s) or range(s) for a specified time period, for example, a redetermination of the phase-dependent signal features and / or corresponding thresholds or ranges may be needed due to a change in a patient condition, change in IMD 14 orientation or other causes.
[0120] When control circuit 206 determines that it is time for an update (“yes” branch of block 364), control circuit 206 may return to block 352 to repeat the process of blocks 352 through 358. When a scheduled time or a triggering condition for an update is not detected, control circuit 206 may continue sensing respiration cycle phases at block 360 using the currently established phase-dependent signal feature(s) and respective thresholds or ranges applied to the phase-dependent signal feature(s).
[0121] FIG. 6 is a flow chart 400 of a method for sensing respiration phases with positive identification of inspiration and expiration by a medical device according to some examples. As described above in conjunction with FIG. 5, in some examples, control circuit 206 may store multiple posture vectors in memory 210 in association with different phase-dependent signal features and / or respective thresholds or ranges to be applied to the phase-dependent signal features for detecting respiration phases when the respectiveAtty Ref. No. A0013476W001posture vector is being detected. As such, at block 402, control circuit 206 may receive an accelerometer signal from sensor 212 for determining a sensed posture vector at block 403 from the DC acceleration axis signal components. Control circuit 206 may compare the sensed posture vector to the posture vectors stored in memory 210 at block 404. A stored posture vector that most closely matches the sensed posture vector may be identified by control circuit 206 at block 404. For example, control circuit 206 may determine an angle between the sensed posture vector and each stored posture vector and identify the stored posture vector having the smallest angular difference from the sensed posture vector. Control circuit 206 may determine the stored posture vector that is most closely aligned with the sensed posture vector based on differences between the accelerometer axis signal magnitudes and / or the directional differences between the sensed posture vector and the stored posture vectors.
[0122] While not shown explicitly in FIG. 6, it is to be understood that in some examples when a posture vector is detected at block 403 that is not determined to match any stored posture vectors, the detected posture vector may be identified as a new posture vector which may be triggering condition detected at block 364 of FIG. 5 as described above. A respiration vector and a phase-dependent signal feature for sensing respiration may be determined and stored for the new posture vector. Any phase-dependent monitoring or therapy delivery functions may be temporarily suspended while the respiration vector and phase-dependent signal feature is determined for the new posture vector.
[0123] When the currently detected posture vector is matched to a stored posture vector at block 404, control circuit 206 may select at least one phase-dependent signal feature stored in memory 210 for the stored posture vector identified as the best match (e.g., most closely aligned) to the detected posture vector. The phase-dependent signal feature may be a feature of a single axis acceleration signal received from sensor 212. A single axis signal may be sufficiently sensitive to respiratory motion to provide reliable respiration phase sensing when a given posture vector is identified. By sensing respiration phase from a single axis signal or signal derived therefrom, power requirements can be lower because other axes of the multi-axis accelerometer signal may be powered off unless utilized by other functions of the device.
[0124] In other examples, the phase-dependent signal feature may be a feature of a combination of two or more accelerometer axis signals (e.g., A1+A2, A2+A3, A1+A3 orAtty Ref. No. A0013476W001A1+A2+A3 or signals derived therefrom). When the phase dependent signal feature is a feature of an acceleration signal (sensed from one or a combination of accelerometer axes), the signal feature may be a maximum slope of the acceleration signal, a maximum peak of the acceleration signal, a positive to negative or a negative to positive zero crossing, or other acceleration signal feature as examples. The signal feature may be determined from a low pass filtered acceleration signal that may or may not be a rectified signal, from a difference signal, or from a velocity or displacement signal determined by performing an integration operation on the acceleration signal. When the acceleration signal feature meets a respective threshold or range stored in memory 210 at block 408 for positively detecting a specified respiration phase, control circuit 206 may detect the associated respiration phase, e.g., inspiration, at block 410. When the acceleration signal feature does not meet the respective threshold or range at block 408, control circuit 206 may continue detecting the previously detected, other respiration phase, e.g., expiration.
[0125] In other examples, the phase-dependent signal feature selected at block 406 for monitoring for respiration phase may be a feature of a signal that is not an acceleration signal but is a feature of another signal sensed by IMD 14. One example of a signal feature that may be respiration phase-dependent is R-wave peak amplitude which can be determined from a sensed cardiac electrical signal (e.g., EGM or ECG signal). Other respiration phase-dependent signal features can be identified from signals sensed by IMD 14 (e.g., by sensor(s) 213 shown in FIG. 3) that change in correlation with the direction of motion along the respiration vector.
[0126] In some instances, the same phase-dependent signal feature may be identified and stored as a respiration phase-dependent signal feature for two or more different posture vectors. The same threshold or range for detecting a specific respiration phase may be stored for the same phase-dependent signal feature for different posture vectors. It is noted that the phase-dependent signal features and corresponding thresholds or ranges for sensing respiration may be the same or different for the different posture vectors. It is possible that the same phase-dependent signal feature(s) and threshold(s) or range(s) are identified for multiple posture vectors such that control circuit 206 may omit determining a posture vector at block 403 because the same phase-dependent signal feature(s) and threshold(s) or range(s) may be used for sensing respiration independent of the posture vector. In some cases, however, different posture-dependent thresholds or ranges forAtty Ref. No. A0013476W001detecting a specified respiration phase (inspiration or expiration) may be stored for the same respiration phase-dependent signal feature and different posture vectors.
[0127] In an illustrative example, the peak acceleration of a single axis signal from motion sensor 212 may exceed a first threshold in the inspiration phase when a first posture vector is detected. The peak acceleration of the same single axis signal may not cross the first threshold when a second posture vector is detected, however. As such, when the second posture vector is detected, the peak acceleration of a combination of two single axis signals may be compared to a second threshold for detecting inspiration. In this case, control circuit 206 may determine the posture vector at block 403 for enabling respiration phase sensing using the appropriate phase-dependent signal feature and / or threshold, range or other criteria (e.g., an increasing trend, decreasing trend, etc.) applied to detect the phase-dependent signal feature occurring in timed relation to a given respiration phase.
[0128] In another illustrative example, the peak R-wave amplitude may vary between a first maximum during inspiration and a first minimum during expiration when a first posture vector is detected. Depending on the sensing electrode vector and other factors, it is contemplated that peak R-wave amplitude could decrease during inspiration and increase during expiration. A first posture dependent threshold that is between the first maximum and first minimum may be stored in association with the first posture vector. Control circuit 206 may detect inspiration (block 410) when the R-wave peak amplitude is detected to fall below the first posture-dependent threshold (at block 408) or is determined to present a decreasing trend. The peak R-wave amplitude may vary between a second maximum during inspiration and a second minimum during expiration when a second posture vector is identified, where one or both of the second maximum and second minimum are different than the first maximum and second minimum, respectively. A second posture dependent threshold (different than the first posture dependent threshold) that is between the second maximum and second minimum R-wave peak amplitude may be stored in memory 210 in association with the second posture vector. When the second posture vector is identified at block 404, control circuit 206 may detect inspiration (block 410) in response to the R-wave peak amplitude falling below the second posturedependent threshold or presents a decreasing trend at block 408.
[0129] In various examples, different phase-dependent signal features or different combinations of phase-dependent signal features may be identified and stored forAtty Ref. No. A0013476W001detecting respiration phase for different posture vectors. When the same phase-dependent signal feature is stored for more than one posture vector, the same thresholds, ranges or other criteria or different posture-dependent thresholds, ranges or other criteria (e.g., trend direction, etc.) may be stored for the given phase-dependent signal feature for the different posture vectors. As such, based on the identified stored posture vector that most closely matches the sensed posture vector at block 404, control circuit 206 selects, at block 406, the stored phase-dependent signal feature(s) and respective threshold(s) or range(s) or other criteria corresponding to the identified stored posture vector for use in sensing respiration phases at block 408 and 410. At block 408, a phase-dependent signal feature meeting a respective threshold, range or other criteria is detected. At block 410, the corresponding respiration phase is detected.
[0130] At block 412, control circuit 206 may perform a respiration monitoring and / or therapy delivery function for the detected inspiration or expiration phase. In some examples, the function may be to wait for the next respiration phase. In other examples, the function may be to determine a respiration metric from the acceleration signal or another signal sensed during the detected respiration phase. Additionally or alternatively, the function may be to stop, start or adjust a therapy delivered by therapy delivery circuit 202, e.g., an electrical stimulation rate may be varied between respiration phases. The electrical stimulation may be delivered by IMD 14 or a co-implanted device for providing cardiac pacing. In other examples, the electrical stimulation may be delivered by IMD 14 or a co-implanted device to a nerve for providing treatment for a breathing disorder, e.g., electrical stimulation of the upper airways, diaphragm or a nerve.
[0131] As control circuit 206 is sensing respiration phases and controlling one or more monitoring and / or therapy delivery functions according to the detected respiration phases, control circuit 206 may monitor the accelerometer signal for detecting a change in the sensed posture vector at block 414. If a change in the posture vector is detected, control circuit 206 may return to block 404 to identify a different stored posture vector that is most closely aligned with the detected new posture vector. The phase-dependent signal feature and / or a posture-dependent threshold, range or other criteria to be applied to the phasedependent signal feature stored in memory 210 for the identified posture vector may be selected at block 406. In this way, sensing respiration phases may continue without interruption as the patient changes posture. When no posture change is detected at blockAtty Ref. No. A0013476W001414, control circuit 206 can continue monitoring the same phase-dependent signal feature at block 408. As indicated above, when the same phase-dependent signal feature(s) and respective threshold(s), range(s) or other criteria can be applied for sensing respiration phase for multiple different posture vectors, block 414 can be omitted.
[0132] FIG. 7 is a diagram 450 accelerometer axis signals 452, 454 and 456 that may be received by control circuit 206 over a respiration cycle. The accelerometer axis signals 452, 454 and 456 include acceleration signal spikes corresponding to cardiac motion and may include other acceleration variations due to other patient body motion or other acceleration forces imposed on motion sensor 212. Changes in the peak-to-peak amplitudes of the acceleration signal spikes associated with cardiac motion in each of the Al, A2 and A3 axis signals 452, 454 and 456 are observed over the respiration cycle, denoted by the expiration phase 460 and inspiration phase 462. The respiration phase, however, may not be readily apparent from observation of the axis signals 452, 454 and 456 and may not be positively determined by control circuit 206 from the axis signals 452, 454 and 456 without an orienting input according to the techniques described above in conjunction with FIG. 4.
[0133] As observed in the example of FIG. 7, for example, the peak-to-peak signal amplitudes 470 increase in the Al axis signal 452 earlier than the start of the inspiration phase 462 and decrease again (peak to peak amplitude 472) prior to the end of the inspiration phase 462. The variation in peak amplitudes of the signal spikes in the A3 axis signal 456 between the expiration phase 460 and inspiration phase 462 is less distinct than in the Al axis signal 452 and A2 axis signal 454. The increase in positive peak amplitude 476 of cardiac motion signal spikes in the A2 axis signal appears to be approximately in phase with the inspiration phase 462 followed by a decrease in the positive peak amplitude 478 in the expiration phase 460.
[0134] In this example, a phase-dependent signal feature may be determined by control circuit 206 from the A2 axis signal 454 for use in sensing respiration phases after positively identifying the direction of motion along a respiration vector according to the techniques disclosed herein and correlating the change in the phase-dependent signal feature with the direction of motion along the respiration vector. Time segments of the axis signals 452, 454 and 456 that correspond to the inspiration and expiration phases may be positively identified by tracking the direction of motion along the respiration vector overAtty Ref. No. A0013476W001one or more respiration cycles. The axis signals 452, 454 and 456, sensed during each positively identified respiration phase 460 and 462, may be analyzed, individually and / or in combinations, by control circuit 206 for detecting a phase-dependent signal feature that presents a consistent and detectable change that occurs in timed relation with the respiration phases (e.g., start / end points of respiration phases) for use in sensing respiration phases. The phase-dependent signal feature may be identified for sensing respiration phases at least when the posture vector being detected at the time that the axis signals 452, 454 and 456 were recorded is being detected. In this example, a phasedependent signal feature may be determined from the A2 axis signal 454 after determining a low pass filtered A2 axis signal for attenuating the higher frequency cardiac motion in the acceleration signal, for instance.
[0135] FIG. 8 is a diagram 500 of a respiration vector 502 that may be determined by control circuit 206. Respiration vector 502 may be determined from a displacement signal determined from the three axis signals (e.g., axis signals 452, 454 and 456 shown in FIG.7) of the three dimensional accelerometer of sensor 212. As described above in conjunction with FIG. 4, the respiration vector 502 may be determined by performing integration methods on the acceleration signal twice to obtain a displacement signal over multiple respiration cycles. The displacement signal may be determined using dead reckoning methods to determine the three dimensional sample point location (al (t), a2(t), a3(t)) at sample times t throughout one or more respiration cycles.
[0136] The x, y, and z coordinates given by the amplitude of the displacement signal determined from the Al, A2 and A3 axis signals at a given time point can correspond to a local coordinate system defined by the Al, A2 and A3 axes of the accelerometer (as shown in FIG. 7). The maximum displacement from a starting point during each phase of respiration may define the endpoints 508 and 510 of the respiration vector 502. For example, the approximate maximum displacement in one direction along respiration vector 502 corresponding to endpoint 508 may be defined as a first extrema by the three dimensional coordinates given by (xmin, ymin, zmin) determined from the displacement signal derived from the accelerometer axis signals at a given time point. The maximum displacement in the opposite direction corresponding to endpoint 510 may be defined by a second extrema (xmax, ymax, zmax) determined from the displacement signal derived from the accelerometer axis signals at a different time point. The endpoints 508 and 510Atty Ref. No. A0013476W001represent the approximate maximum displacement of the sensor 212 at the end of each phase of a respiration cycle. However, the direction of motion along the respiration vector 502 corresponding to inspiration and expiration phases may be unknown. In order to identify which direction of motion along respiration vector 502 corresponds to inspiration and which direction corresponds to expiration, control circuit 206 may receive an orienting input signal for confirming the timing of the inspiration and expiration cycles corresponding to a respective direction of motion along the respiration vector 502 as described above in conjunction with FIG. 4.
[0137] It may be assumed but not necessarily required that the patient remains in a stable, unchanging posture during the determination of the respiration vector 502. As described above in conjunction with FIG. 5, a respiration vector may be determined for multiple different patient postures by detecting two or more different posture vectors and determining corresponding respiration vectors. As such, respiration vector 502 may represent the respiration vector determined by control circuit 206 and stored in memory 210 (e.g., as defined by end points 508 and 510) for a given posture vector, P, 514. For instance, posture vector P 514 may correspond to a patient posture that is upright when the respiration vector 502 is determined. In other examples, the respiration vector 502 may be determined to be sufficiently representative of the direction of motion over respiration cycles during multiple different posture vectors such that separate phase-dependent signal features and associated thresholds / ranges / criteria that enable the phase-dependent signal feature to be detected to sense inspiration or expiration need not be determined and stored for different posture vectors. In still other examples, phase-dependent respiration monitoring and / or therapy delivery functions may be performed during specified time(s) of day when the patient is expected to be substantially in one, primary posture, e.g., an upright position (e.g., during daytime hours) or a non-upright position (e.g., during nighttime hours). In this case, the respiration vector can be determined for one expected primary posture to enable control circuit 206 to sense respiration phases during the given time(s) of day for performing the phase-dependent respiration monitoring and / or delivering phase-dependent therapy.
[0138] FIG. 9 is a diagram 520 depicting an orienting signal input that may be sensed or received by the medical device system for positively identifying a direction of motion along a respiration vector corresponding to a respiration phase. When the respirationAtty Ref. No. A0013476W001vector 502 (FIG. 8) is determined, control circuit 206 may not be able to positively identify the direction of motion during inspiration vs. during expiration that occurs along the respiration vector 502 without receiving an orienting input signal.
[0139] In some examples, control circuit 206 may receive a timing signal 530 indicating a time point of the inspiration phase and / or timing signal 534 indicating a time point of the expiration phase. In this example, another medical device, e.g., external device 50 may transmit the timing signal 530 and / or timing signal 534, which may be in response to receiving a user input via user interface 56 (see FIG. 1). In some examples, the timing signals 530 and / or 534 may be transmitted by a second device, e.g., external device 50 or another co-implanted device, such as cardiac monitor 62 shown in FIG. 1. The timing signals may be generated in response to identifying the respiration phases from a signal sensed or received by the second device, e.g., from orienting signal source 60 or a signal sensed by cardiac monitor 62.
[0140] In an illustrative example, the second medical device may be configured to sense or receive an ECG signal 522 and determine R-wave peak amplitudes 525. R-wave peak amplitudes 525 may normally increase during expiration and decrease during inspiration when the ECG signal is sensed via surface electrodes or subcutaneous electrodes. The second device may determine when the R-wave peak amplitude 525 is decreasing and generate an inspiration timing signal 530 that is transmitted to IMD 14 as an orienting input received by control circuit 206. The direction 506 of motion along the respiration vector 502 during a time interval 532 corresponding to the received timing signal 530 may be determined by control circuit 206 as the direction of motion during the inspiration phase. Control circuit 206 may identify the inspiration (INSP) motion direction 506 (shown in FIG. 8) based on changes in displacement signal sample points that occur over a time interval 532 that may begin or end with the inspiration timing signal 530 or encompass the time of the inspiration timing signal 530. Displacement in the opposite direction 504 of the respiration vector 502 may be identified as the direction of motion during expiration (EXP).
[0141] Additionally or alternatively, the second medical device may transmit an expiration timing signal 534 in response to detecting increasing R-wave peak amplitudes 527. The expiration timing signal 534 may be received by control circuit 206 as an orienting input for use in determining the direction of motion along the respiration vector 502 during theAtty Ref. No. A0013476W001expiration phase. Control circuit 206 may determine a direction 504 of motion along respiration vector 502 during a time interval 536 relative to the time of the timing signal 534. The time interval 536 may start or end with expiration timing signal 534 or encompasses the time of timing signal 534. The direction 504 of motion along the respiration vector 502 during the time interval 536 may be identified by control circuit 206 as the expiration phase. While R-wave peak amplitudes determined from an ECG signal from a second device are given here as an illustrative example of an orienting signal source that can be useful in positively identifying respiration phases, other orienting signal sources may be used e.g., as described above in conjunction with FIG. 4.
[0142] FIG. 10 is a diagram 550 of an orienting input signal 552 that may be sensed or received by the medical device system 10 according to another example. In this example, the orienting input signal 552 includes breath hold intervals 560 and may be received by control circuit 206 from motion sensor 212 as an orienting input signal. In this example, the orienting input signal 552 may be a displacement signal that can be obtained from the acceleration axis signals as a low pass filtered and smoothed signal representing the cyclical changes in position of the motion sensor over one or more respiration cycles. In this example, the patient may be instructed to perform a breath hold for a specified number of seconds at the end of each inspiration phase.
[0143] Control circuit 206 may detect a plateau of the change in position over a time period 560 that matches the expected breath hold duration. The patient may be instructed to perform a breath hold of the specified time period at the end of inspiration, for example. In this way, control circuit 206 is enabled to determine a direction of motion along the respiration vector during a time interval 562 that precedes the breath hold interval 560 as the direction of motion during inspiration. Additionally or alternatively, control circuit 206 may determine a direction of motion along the respiration vector during a time interval 564 that follows the breath hold time period 560 during the expiration phase. When the direction of motion along the respiration vector is detected from one respiration phase, e.g., inspiration or expiration, the opposite direction of motion can be determined to be the direction of motion during the other respiration phase, e.g., expiration or inspiration. Thus, in some examples, the orienting input received by control circuit 206 may be a signal sensed by IMD 14 that includes a plateau or other detectable characteristic in the signal forAtty Ref. No. A0013476W001a breath hold duration so that a time of the breath hold that occurs in timed relation to a respiration phase can be detected.
[0144] FIG. 11 is a diagram 650 of a signal 651 sensed by IMD 14 that may be analyzed by control circuit 206 over one or more respiration cycles of positively identified respiration phases based on the determined directions of motion along the respiration vector during each respiration phase. Signal 651 may be an acceleration signal sensed by motion sensor 212 from one or a combination of sensor axes. Signal 651 could represent a signal sensed by IMD 14 that is not necessarily sensed by motion sensor 212, however. Signal 651 may represent any signal that is sensed by IMD 14, e.g., by sensor(s) 213 shown in FIG. 3, and can be analyzed for detecting and characterizing a phase-dependent signal feature. Signal 651 may be analyzed by control circuit 206 for identifying a phasedependent signal feature that occurs in timed relation to the determined directions of motion along the respiration vector during each respiration phase. After identifying a phase-dependent feature of signal 651, control circuit 206 can subsequently detect when the signal feature meets a threshold, range or other criteria for sensing respiration phases.
[0145] Having identified the direction of inspiration along the respiration vector 502 that corresponds to inspiration, e.g., according to the techniques described above in conjunction with FIGs. 8, 9 and 10, control circuit 206 may identify, for example, a feature of the sensed signal 651 that occurs in timed relation to the direction of motion along respiration vector during the inspiration phase. For example, control circuit 206 may detect the inspiration phase 670 in response to detecting a positive to negative going crossing 652 of the threshold 674. Control circuit 206 may detect the expiration phase 672 in response to detecting a negative to positive going crossing 654 of the threshold 674. The phase-dependent signal feature of the sensed signal 651, in this case amplitudes less than threshold 674 and amplitudes greater than threshold 674, that corresponds to the inspiration and expiration phases, respectively, may not be known without identifying the direction of motion along the respiration vector based on an orienting input and subsequently characterizing the phase-dependent feature of the signal 651 during one or both of the positively identified respiration phases. By determining a phase-dependent signal feature of a signal 651 sensed by IMD 14 that changes in timed relation to changes in the direction of motion along the respiration vector 502, control circuit 206 can subsequently sense respiration phases by detecting the phase-dependent signal featureAtty Ref. No. A0013476W001according to the methods described herein for performing phase-dependent respiration metric monitoring and / or phase-dependent therapy delivery functions. The respiration phase sensing may be improved over time with repetition of the respiration vector orientation and / or sensed signal feature analysis to isolate repeatable measures of the identified phase-dependent signal features.
[0146] Further disclosed herein is the subject matter of the following examples:
[0147] Example 1. A medical device system including sensing circuitry configured to sense one or more signals, the sensing circuitry comprising at least a motion sensor sensing a motion signal. The medical device system includes control circuitry configured to receive the motion signal sensed by the motion sensor for at least one respiration cycle and determine from the motion signal a first respiration vector representative of directions of motion during the at least one respiration cycle. The control circuitry may be further configured to identify a first direction of motion along the first respiration vector corresponding to a first respiration phase that is one of an inspiration phase or an expiration phase of the at least one respiration cycle and, from the one or more signals sensed by the sensing circuitry, identify a first phase-dependent signal feature that occurs in timed relation with the first direction of motion along the first respiration vector. The control circuitry may be further configured to sense respiration phases by detecting the first phase-dependent signal feature.
[0148] Example 2. The medical device system of example 1 wherein the control circuitry is further configured to receive an orienting input signal and determine the first direction of motion along the first respiration vector corresponding to the first respiration phase based on the orienting input signal.
[0149] Example 3. The medical device system of example 2 further including a first communication circuit configured to receive the orienting input signal as a communication signal. The control circuitry may be further configured to receive the orienting input signal via the first communication circuit.
[0150] Example 4. The medical device system of example 3 further including an implantable medical device including the sensing circuitry, the control circuitry and the first communication circuit. The medical device system may further include a second medical device configured to transmit the communication signal.Atty Ref. No. A0013476W001
[0151] Example 5. The medical device system of example 4 wherein the second medical device includes a user interface configured to receive a user entered respiration phase input and a second communication circuit configured to transmit the communication signal in response to the user entered respiration phase input.
[0152] Example 6. The medical device system of example 4 wherein the second medical device is further configured to receive a signal correlated to respiration, detect a timing of the first respiration phase or a second respiration phase that is the other one of the inspiration phase or the expiration phase and transmit the communication signal in response to detecting the timing.
[0153] Example 7. The medical device system of example 2 wherein the control circuitry is further configured to receive the orienting input signal from the sensing circuitry, detect a breath hold time period from the orienting input signal and detect a timing of the first respiration phase based on the breath hold time period detection. The control circuitry may be configured to identify the first direction of motion along the first respiration vector corresponding to the first respiration phase relative to the detected timing of the first respiration phase.
[0154] Example 8. The medical device system of any one of examples 1 — 7 wherein the control circuitry is further configured to determine a phase-dependent respiration metric from the motion signal sensed during one of the inspiration phase or the expiration phase of the sensed respiration phases.
[0155] Example 9. The medical device system of example 8 further including a communication circuit configured to transmit a notification signal and a therapy delivery circuit configured to deliver a therapy. The control circuitry may be further configured to detect a change in the phase-dependent respiration metric and respond to the detected change by at least one of: controlling the communication circuit to transmit the notification signal or controlling the therapy delivery circuit to one of start, stop or adjust the therapy.
[0156] Example 10. The medical device system of any one of examples 1 — 9 further including a first communication circuit. The control circuitry may be further configured to control the first communication circuit to transmit a respiration phase detection signal in timed relation to detecting the first phase-dependent signal feature.Atty Ref. No. A0013476W001
[0157] Example 11. The medical device system of any one of examples 1 — 10 further including a therapy delivery circuit configured to deliver a therapy. The control circuitry may be further configured to control the therapy delivery circuit to deliver the therapy by varying the therapy between the sensed respiration phases.
[0158] Example 12. The medical device system of example 11 wherein the therapy delivery circuit is configured to deliver the therapy by delivering electrical stimulation pulses and the control circuitry is further configured to control the therapy delivery circuit to vary the therapy between the sensed respiration phases by varying a rate of the electrical stimulation pulses between the sensed respiration phases.
[0159] Example 13. The medical device system of any one of examples 11 — 12 wherein the therapy delivery circuit is configured to deliver the electrical stimulation pulses as cardiac pacing pulses.
[0160] Example 14. The medical device system of any one of examples 1 — 13 wherein the control circuitry is further configured to determine that a respiration phase is not sensed for a specified time interval and redetermine the respiration vector in response to determining that the respiration phase is not sensed for the specified time interval.
[0161] Example 15. The medical device system of any one of examples 1 — 14 further including a memory configured to store a plurality of posture vectors. The control circuitry may be further configured to determine a first posture vector from the motion signal, determine the first respiration vector in association with the first posture vector, and store, in the memory, the first phase-dependent signal feature in association with the first posture vector stored in the memory as one of the plurality of posture vectors. The control circuitry may be further configured to detect a first subsequent patient posture vector from the motion signal, determine that the first subsequent patient posture vector matches the first posture vector and sense the respiration phases by detecting the first phase-dependent signal feature when the first subsequent patient posture vector that matches the first posture vector is being detected.
[0162] Example 16. The medical device system of example 15 wherein the control circuitry is further configured to determine a second posture vector from the motion signal, determine a second respiration vector in association with the second posture vector, identify a second direction of motion along the second respiration vector corresponding to the first respiration phase and determine a second phase-dependent signal feature from theAtty Ref. No. A0013476W001one or more signals sensed by the sensing circuitry, the second phase-dependent signal feature being identified as occurring in association with the second direction of motion along the second respiration vector. The control circuitry may store, in the memory, the second phase-dependent signal feature in association with the second posture vector stored in the memory as one of the plurality of posture vectors. The control circuitry may be configured to detect a second subsequent patient posture vector that matches the second posture vector and sense the respiration phases by detecting the second phase-dependent signal feature when the second subsequent patient posture vector that matches the second posture vector is being detected.
[0163] Example 17. The medical device system of any one of examples 1 — 16 wherein the control circuitry is further configured to determine the first phase-dependent signal feature from the motion signal.
[0164] Example 18. The medical device system of any one of examples 1 — 17 wherein the control circuit is further configured to determine the first phase-dependent signal feature by determining one of a peak magnitude or a peak slope.
[0165] Example 19. The medical device system of any one of examples 1 — 18 wherein the motion sensor is a multi-axis motion sensor and the control circuitry is further configured to determine the first respiration vector by determining a displacement signal from the motion signal sensed by the multi -axis motion sensor, determining a maximum displacement point during the at least one respiration cycle, determining a minimum displacement point during the at least one respiration cycle and determining the respiration vector between the maximum displacement point and the minimum displacement point.
[0166] Example 20. The medical device of any one of examples 1 — 19 wherein the sensing circuitry includes a cardiac signal sensing circuit configured to sense a cardiac signal and the control circuitry is further configured to determine the first phase-dependent signal feature from the cardiac signal.
[0167] Example 21. A method including sensing one or more signals including at least a motion signal sensed by a motion sensor, sensing the motion signal for at least one respiration cycle and determining from the motion signal a first respiration vector representative of directions of motion during the at least one respiration cycle. The method may include identifying a first direction of motion along the respiration vector corresponding to a first respiration phase that is one of an inspiration phase or anAtty Ref. No. A0013476W001expiration phase of the at least one respiration cycle and, from the one or more sensed signals, identifying a first phase-dependent signal feature that occurs in timed relation with the first direction of motion along the first respiration vector. The method may further include sensing respiration phases by detecting the first phase-dependent signal feature.
[0168] Example 22. The method of example 21 further including receiving an orienting input signal and determining the first direction of motion along the first respiration vector corresponding to the first respiration phase based on the orienting input signal.
[0169] Example 23. The method of example 22 further including receiving the orienting input signal as a communication signal.
[0170] Example 24. The method of example 23 further including receiving the orienting input signal as a communication signal by a first medical device of a medical device system and transmitting the communication signal by a second medical device of the medical device system.
[0171] Example 25. The method of example 24 further including receiving a user entered respiration phase input by the second medical device and transmitting the communication signal in response to receiving the user entered respiration phase input.
[0172] Example 26. The method of example 24 further including receiving a signal correlated to respiration by the second medical device and detecting a timing of the first respiration phase or a second respiration phase that is the other one of the inspiration phase or the expiration phase and transmitting the communication signal in response to detecting the timing.
[0173] Example 27. The method of example 22 further including receiving the orienting input signal as one of the one or more sensed signals, detecting a breath hold time period from the orienting input signal, and detecting a timing of the first respiration phase based on the breath hold time period detection. The method may include identifying the first direction of motion along the first respiration vector corresponding to the first respiration phase relative to the detected timing of the first respiration phase.
[0174] Example 28. The method of any one of examples 21 — 27 further including determining a phase-dependent respiration metric from the motion signal sensed during one of the inspiration phase or the expiration phase of the sensed respiration phases.
[0175] Example 29. The method of example 28 further including detecting a change in the phase-dependent respiration metric and responding to the detected change by at leastAtty Ref. No. A0013476W001one of: transmitting a notification signal or controlling a therapy delivery circuit to one of start, stop or adjust a therapy.
[0176] Example 30. The method of any one of examples 21 — 29 further including transmitting a respiration phase detection signal in timed relation to detecting the first phase-dependent signal feature.
[0177] Example 31. The method of any one of examples 21 — 30 further including delivering a therapy by a therapy delivery device and varying the therapy between the sensed respiration phases.
[0178] Example 32. The method of example 31 further including delivering the therapy by delivering electrical stimulation pulses and varying the therapy between the sensed respiration phases by varying a rate of the electrical stimulation pulses between the sensed respiration phases.
[0179] Example 33. The method of any one of examples 31 — 32 further including delivering the electrical stimulation pulses as cardiac pacing pulses.
[0180] Example 34. The method of any one of examples 31 — 33 further including determining that a respiration phase is not sensed for a specified time interval and redetermining the respiration vector in response to determining that the respiration phase is not sensed for the specified time interval.
[0181] Example 35. The method of any one of examples 31 — 34 further including determining a first posture vector from the motion signal, determining the first respiration vector in association with the first posture vector and storing, in a memory, the first phasedependent signal feature in association with the first posture vector. The method may include detecting a first subsequent patient posture vector from the motion signal, determining that the first subsequent patient posture vector matches the first posture vector and sensing the respiration phases by detecting the first phase-dependent signal feature when the first subsequent patient posture vector that matches the first posture vector is being detected.
[0182] Example 36. The method of example 35 further including determining a second posture vector from the motion signal, determining a second respiration vector in association with the second posture vector, identifying a second direction of motion along the second respiration vector corresponding to the first respiration phase and determining a second phase-dependent signal feature from the one or more sensed signals, the secondAtty Ref. No. A0013476W001phase-dependent signal feature being identified as occurring in association with the second direction of motion along the second respiration vector. The method may include storing, in the memory, the second phase-dependent signal feature in association with the second posture vector. The method may include detecting a second subsequent patient posture vector that matches the second posture vector and sensing the respiration phases by detecting the second phase-dependent signal feature when the second subsequent patient posture vector that matches the second posture vector is being detected.
[0183] Example 37. The method of any one of examples 21 — 36 further including determining the first phase-dependent signal feature from the motion signal.
[0184] Example 38. The method of any one of examples 21 — 37 further including determining the first phase-dependent signal feature by determining one of a peak magnitude or a peak slope.
[0185] Example 39. The method of any one of examples 21 — 38 further including sensing the motion signal by a multi-axis motion sensor and determining the first respiration vector by determining a displacement signal from the motion signal sensed by the multi -axis motion sensor, determining a maximum displacement point during the at least one respiration cycle, determining a minimum displacement point during the at least one respiration cycle and determining the respiration vector between the maximum displacement point and the minimum displacement point.
[0186] Example 40. The method of any one of examples 21 — 39 further including sensing the one or more signals by sensing a cardiac signal and determining the first phase-dependent signal feature from the cardiac signal.
[0187] Example 41. A non-transitory computer readable medium storing instructions which, when executed by control circuitry of a medical device system, cause the medical device system to sense one or more signals including at least a motion signal sensed by a motion sensor, sense the motion signal for at least one respiration cycle and determine from the motion signal a respiration vector representing directions of motion during the at least one respiration cycle. The instructions may further cause the medical device system to identify a first direction of motion along the respiration vector corresponding to one of an inspiration phase or an expiration phase of the at least one respiration cycle and, from the one or more sensed signals, determine a phase-dependent signal feature that occurs in timed relation with the identified first direction of motion along the respiration vector. TheAtty Ref. No. A0013476W001instructions may further cause the medical device system to sense respiration phases by detecting the phase-dependent signal feature. The medical device system may perform a phase-dependent monitoring and / or therapy delivery function in response to sensing the respiration phases.
[0188] It should be understood that, depending on the example, certain acts or events of any of the methods described herein can be performed in a different sequence, may be added, merged, or left out altogether (e.g., not all described acts or events are necessary for the practice of the method). Moreover, in certain examples, acts or events may be performed concurrently, e.g., through multi-threaded processing, interrupt processing, or multiple processors, rather than sequentially. In addition, while certain aspects of this disclosure are described as being performed by a single circuit or unit for purposes of clarity, it should be understood that the techniques of this disclosure may be performed by a combination of units or circuits associated with, for example, a medical device.
[0189] In one or more examples, the functions described may be implemented in hardware, software, firmware, or any combination thereof. If implemented in software, the functions may be stored as one or more instructions or code on a computer-readable medium and executed by a hardware-based processing unit. Computer-readable media may include computer-readable storage media, which corresponds to a tangible medium such as data storage media (e.g., RAM, ROM, EEPROM, flash memory, or any other medium that can be used to store desired program code in the form of instructions or data structures and that can be accessed by a computer).
[0190] Instructions may be executed by one or more processors, such as one or more digital signal processors (DSPs), general purpose microprocessors, application specific integrated circuits (ASICs), field programmable logic arrays (FPLAs), or other equivalent integrated or discrete logic circuitry. Accordingly, the term “processor,” as used herein may refer to any of the foregoing structure or any other structure suitable for implementation of the techniques described herein. Also, the techniques could be fully implemented in one or more circuits or logic elements.
[0191] Thus, a medical device has been presented in the foregoing description with reference to specific examples. It is to be understood that various aspects disclosed herein may be combined in different combinations than the specific combinations presented in the accompanying drawings. It is appreciated that various modifications to the referencedAtty Ref. No. A0013476W001examples may be made without departing from the scope of the disclosure and the following claims.
Claims
Atty Ref. No. A0013476W001WHAT IS CLAIMED IS:
1. A medical device system comprising:sensing circuitry configured to sense one or more signals, the sensing circuitry comprising at least a motion sensor sensing a motion signal; andcontrol circuitry configured to:receive the motion signal sensed by the motion sensor for at least one respiration cycle;determine from the motion signal a first respiration vector representative of directions of motion during the at least one respiration cycle;identify a first direction of motion along the first respiration vector corresponding to a first respiration phase that is one of an inspiration phase or an expiration phase of the at least one respiration cycle;from the one or more signals sensed by the sensing circuitry, identify a first phase-dependent signal feature that occurs in timed relation with the first direction of motion along the first respiration vector; andsense respiration phases by detecting the first phase-dependent signal feature.
2. The medical device system of claim 1 wherein the control circuitry is further configured to:receive an orienting input signal; anddetermine the first direction of motion along the first respiration vector corresponding to the first respiration phase based on the orienting input signal.
3. The medical device system of claim 2 further comprising a first communication circuit configured to receive the orienting input signal as a communication signal; andwherein the control circuitry is further configured to receive the orienting input signal via the first communication circuit.
4. The medical device system of claim 3 further comprising:an implantable medical device comprising:Atty Ref. No. A0013476W001the sensing circuitry;the control circuitry; andthe first communication circuit; anda second medical device configured to transmit the communication signal.
5. The medical device system of claim 4 wherein the second medical device comprises:a user interface configured to receive a user entered respiration phase input; anda second communication circuit configured to transmit the communication signal in response to the user entered respiration phase input.
6. The medical device system of claim 4 wherein the second medical device is further configured to:receive a signal correlated to respiration;detect a timing of the first respiration phase or a second respiration phase that is the other one of the inspiration phase or the expiration phase; andtransmit the communication signal in response to detecting the timing.
7. The medical device system of claim 2 wherein the control circuitry is further configured to:receive the orienting input signal from the sensing circuitry;detect a breath hold time period from the orienting input signal; detect a timing of the first respiration phase based on the breath hold time period detection; andidentify the first direction of motion along the first respiration vector corresponding to the first respiration phase relative to the detected timing of the first respiration phase.
8. The medical device system of any one of claims 1 — 7 wherein the control circuitry is further configured to determine a phase-dependent respiration metric from theAtty Ref. No. A0013476W001motion signal sensed during one of the inspiration phase or the expiration phase of the sensed respiration phases.
9. The medical device system of claim 8 further comprising:a communication circuit configured to transmit a notification signal; and a therapy delivery circuit configured to deliver a therapy; andwherein the control circuitry is further configured to:detect a change in the phase-dependent respiration metric; and respond to the detected change by at least one of:controlling the communication circuit to transmit the notification signal; orcontrolling the therapy delivery circuit to one of start, stop or adjust the therapy.
10. The medical device system of any one of claims 1 — 9 further comprising a therapy delivery circuit configured to deliver a therapy; andwherein the control circuitry is further configured to control the therapy delivery circuit to deliver the therapy by varying the therapy between the sensed respiration phases.
11. The medical device system of claim 10 wherein:the therapy delivery circuit is configured to deliver the therapy by delivering electrical stimulation pulses;the control circuitry is further configured to control the therapy delivery circuit to vary the therapy between the sensed respiration phases by varying a rate of the electrical stimulation pulses between the sensed respiration phases.
12. The medical device system of any one of claims 10 — 11 wherein the therapy delivery circuit is configured to deliver the electrical stimulation pulses as cardiac pacing pulses.Atty Ref. No. A0013476W00113. The medical device system of any one of claims 1 — 12 further comprising a memory configured to store a plurality of posture vectors:wherein the control circuitry is further configured to:determine a first posture vector from the motion signal;determine the first respiration vector in association with the first posture vector;store, in the memory, the first phase-dependent signal feature in association with the first posture vector stored in the memory as one of the plurality of posture vectors;detect a first subsequent patient posture vector from the motion signal; determine that the first subsequent patient posture vector matches the first posture vector; andsense a first portion of the sensed respiration phases by detecting the first phase-dependent signal feature when the first subsequent patient posture vector that matches the first posture vector is being detected.
14. The medical device system of claim 13 wherein the control circuitry is further configured to:determine a second posture vector from the motion signal;determine a second respiration vector in association with the second posture vector;identify a second direction of motion along the second respiration vector corresponding to the first respiration phase;determine a second phase-dependent signal feature from the one or more signals sensed by the sensing circuitry, the second phase-dependent signal feature being identified as occurring in association with the second direction of motion along the second respiration vector;store, in the memory, the second phase-dependent signal feature in association with the second posture vector stored in the memory as one of the plurality of posture vectors;detect a second subsequent patient posture vector that matches the second posture vector; andAtty Ref. No. A0013476W001sense a second portion of the sensed respiration phases by detecting the second phase-dependent signal feature when the second subsequent patient posture vector that matches the second posture vector is being detected.
15. The medical device system of any one of claims 1 — 14 wherein: the motion sensor is a multi-axis motion sensor; andthe control circuitry is further configured to determine the first respiration vector by:determining a displacement signal from the motion signal sensed by the multi-axis motion sensor;determining a maximum displacement point during the at least one respiration cycle;determining a minimum displacement point during the at least one respiration cycle; anddetermining the respiration vector between the maximum displacement point and the minimum displacement point.
